51
|
Yan C, Cui J, Huang L, Du B, Chen L, Xue G, Li S, Zhang W, Zhao L, Sun Y, Yao H, Li N, Zhao H, Feng Y, Liu S, Zhang Q, Liu D, Yuan J. Rapid and visual detection of 2019 novel coronavirus (SARS-CoV-2) by a reverse transcription loop-mediated isothermal amplification assay. Clin Microbiol Infect 2020; 26:773-779. [PMID: 32276116 PMCID: PMC7144850 DOI: 10.1016/j.cmi.2020.04.001] [Citation(s) in RCA: 352] [Impact Index Per Article: 88.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/03/2020] [Revised: 04/01/2020] [Accepted: 04/02/2020] [Indexed: 12/14/2022]
Abstract
OBJECTIVE To evaluate a reverse transcription loop-mediated isothermal amplification (RT-LAMP) assay for detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), and compare it with RT-PCR. METHODS We designed primers specific to the orf1ab and S genes of SARS-CoV-2. Total viral RNA was extracted using the QIAamp Viral RNA Mini Kit. We optimized the RT-LAMP assay, and evaluated it for its sensitivity and specificity of detection using real-time turbidity monitoring and visual observation. RESULTS The primer sets orf1ab-4 and S-123 amplified the genes in the shortest times, the mean (±SD) times were 18 ± 1.32 min and 20 ± 1.80 min, respectively, and 63°C was the optimum reaction temperature. The sensitivities were 2 × 101 copies and 2 × 102 copies per reaction with primer sets orf1ab-4 and S-123, respectively. This assay showed no cross-reactivity with 60 other respiratory pathogens. To describe the availability of this method in clinical diagnosis, we collected 130 specimens from patients with clinically suspected SARS-CoV-2 infection. Among them, 58 were confirmed to be positive and 72 were negative by RT-LAMP. The sensitivity was 100% (95% CI 92.3%-100%), specificity 100% (95% CI 93.7%-100%). This assay detected SARS-CoV-2 in a mean (±SD) time of 26.28 ± 4.48 min and the results can be identified with visual observation. CONCLUSION These results demonstrate that we developed a rapid, simple, specific and sensitive RT-LAMP assay for SARS-CoV-2 detection among clinical samples. It will be a powerful tool for SARS-CoV-2 identification, and for monitoring suspected patients, close contacts and high-risk groups.
Collapse
Affiliation(s)
- C Yan
- Capital Institute of Paediatrics, Beijing, China
| | - J Cui
- Capital Institute of Paediatrics, Beijing, China
| | - L Huang
- Treatment and Research Centre for Infectious Diseases, The Fifth Medical Centre of PLA General Hospital, Beijing, China
| | - B Du
- Capital Institute of Paediatrics, Beijing, China
| | - L Chen
- Beijing Macro & Micro-test Bio-Tech Co., Ltd. Beijing, China
| | - G Xue
- Capital Institute of Paediatrics, Beijing, China
| | - S Li
- Capital Institute of Paediatrics, Beijing, China
| | - W Zhang
- Capital Institute of Paediatrics, Beijing, China
| | - L Zhao
- Capital Institute of Paediatrics, Beijing, China
| | - Y Sun
- Capital Institute of Paediatrics, Beijing, China
| | - H Yao
- Capital Institute of Paediatrics, Beijing, China
| | - N Li
- Capital Institute of Paediatrics, Beijing, China
| | - H Zhao
- Capital Institute of Paediatrics, Beijing, China
| | - Y Feng
- Capital Institute of Paediatrics, Beijing, China
| | - S Liu
- Capital Institute of Paediatrics, Beijing, China
| | - Q Zhang
- Capital Institute of Paediatrics, Beijing, China
| | - D Liu
- Computational Virology Group, Centre for Bacteria and Virus Resources and Bioinformation, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan, China.
| | - J Yuan
- Capital Institute of Paediatrics, Beijing, China.
| |
Collapse
|
52
|
Kouamé M, Niamkey J, Matanga J, Yao H, Ekou A, Kouakou H, Konin C, Anzouan-Kacou J, N’guetta R. Prevalence and risk factors of extra-coronary atherosclerotic disease in patients with confirmed coronary artery disease: A Cross-Sectional Study in Abidjan Heart Institute. Archives of Cardiovascular Diseases Supplements 2020. [DOI: 10.1016/j.acvdsp.2019.09.430] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/01/2022]
|
53
|
Yao H, Farnier M, Salignon-Vernay C, Chagué F, Brunel P, Maza M, Brunet D, Bichat F, Beer J, Cottin Y, Zeller M. Coronary lesion complexity in patients with familial hypercholesterolemia hospitalized for an acute myocardial infarction: Data from the French RICO Survey. Archives of Cardiovascular Diseases Supplements 2020. [DOI: 10.1016/j.acvdsp.2019.09.019] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
|
54
|
Ye S, Lucarelli N, Yao H, Teo, Koshy A, Teh A, Hamer A, Buntine P, Roberts L, Cooke J, Sajeev J. 458 Clinical Utility of Contemporary Guideline-Based High-Risk Features in the Prediction of Cardiac Syncope. Heart Lung Circ 2020. [DOI: 10.1016/j.hlc.2020.09.465] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
55
|
Ye S, Teo A, Lucarelli N, Yao H, Koshy A, Teh A, Buntine P, Hamer A, Cooke J, Roberts L, Sajeev J. 508 Lack of a Discharge Diagnosis following a Presentation With Syncope is Associated With Inadequate Follow-Up. Heart Lung Circ 2020. [DOI: 10.1016/j.hlc.2020.09.515] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
56
|
Ou Q, Lin D, Yu Y, Li A, Zhang W, Chen Y, Liu R, Tan Y, Xu M, Li L, Yao H. Association of MUC16 mutation with survival of immune checkpoint inhibitor in patients with cancer. Ann Oncol 2019. [DOI: 10.1093/annonc/mdz452.013] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
57
|
Yu Y, Zhang W, Li A, Chen Y, Wang Y, Zhang Y, He Z, Ou Q, Liu R, Song E, Yao H. Association of long non-coding RNA biomarkers with clinically immune subtype and prediction of immunotherapy in patients with cancer. Ann Oncol 2019. [DOI: 10.1093/annonc/mdz452.001] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
|
58
|
Li A, Lin D, Yu Y, Gu Y, Ou Q, Zhang W, Chen Y, Liu R, Tan Y, Xu H, Li L, Yao H. Association of PTPRT mutation with survival of immune checkpoint inhibitor in patients with cancer. Ann Oncol 2019. [DOI: 10.1093/annonc/mdz452.014] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
59
|
Yao H, Xu JK, Zheng NY, Wang JL, Mok SW, Lee YW, Shi L, Wang JY, Yue J, Yung SH, Hu PJ, Ruan YC, Zhang YF, Ho KW, Qin L. Intra-articular injection of magnesium chloride attenuates osteoarthritis progression in rats. Osteoarthritis Cartilage 2019; 27:1811-1821. [PMID: 31536815 DOI: 10.1016/j.joca.2019.08.007] [Citation(s) in RCA: 35] [Impact Index Per Article: 7.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 02/20/2019] [Revised: 08/22/2019] [Accepted: 08/30/2019] [Indexed: 02/02/2023]
Abstract
OBJECTIVE To explore the effects of Mg2+ on the expression of osteoarthritic markers in human cartilage and synovium tissue explants. To investigate the therapeutic effect of intra-articular injection of Mg2+ in an established rat OA (Osteoarthritis) model of anterior cruciate ligament transection with partial medial meniscectomy (ACLT + PMM). DESIGN Human cartilage and synovium explants were collected from total knee replacement surgeries and incubated with MgCl2 (20 mmol/L) in vitro. A rat OA model was established by ACLT + PMM surgery in 450-500 g male Sprague Dawley (SD) rats. To select the optimal dose, intra-articular injections of MgCl2 (0.05, 0.5, 5 mol/L) were performed at 4 weeks after the surgery every 3 days for 2 weeks. The effect of optimized MgCl2 was further determined by histology, immunohistochemistry, and quantitative real-time polymerase chain reaction. RESULTS The expressions of osteoarthritic markers in human cartilage and synovium explants were inhibited by Mg2+in vitro. Immunohistochemical analysis further suggested the inhibitory effects of Mg2+ on the expression of MMP-13 and IL-6 in the human tissue explants. Cartilage degeneration and synovitis in ACLT + PMM rats were significantly improved by intra-articular injections of Mg2+ (0.5 mol/L). Immunohistochemical analysis also showed the regulatory effects of Mg2+ on osteoarthritic markers in both cartilage and synovium in rats, consistent with in vitro results. CONCLUSION Intra-articular injections of Mg2+ at 0.5 mol/L attenuate the progression of OA in the ACLT + PMM rat model. Such effect was at least in part explained by the promotion of cartilage matrix synthesis and the suppression of synovial inflammation.
Collapse
Affiliation(s)
- H Yao
- Department of Orthopaedics and Traumatology, The Chinese University of Hong Kong, Hong Kong SAR, PR China.
| | - J K Xu
- Department of Orthopaedics and Traumatology, The Chinese University of Hong Kong, Hong Kong SAR, PR China.
| | - N Y Zheng
- Department of Orthopaedics and Traumatology, The Chinese University of Hong Kong, Hong Kong SAR, PR China.
| | - J L Wang
- Department of Orthopaedics and Traumatology, The Chinese University of Hong Kong, Hong Kong SAR, PR China.
| | - S W Mok
- Department of Orthopaedics and Traumatology, The Chinese University of Hong Kong, Hong Kong SAR, PR China.
| | - Y W Lee
- Department of Orthopaedics and Traumatology, The Chinese University of Hong Kong, Hong Kong SAR, PR China.
| | - L Shi
- Department of Orthopaedics and Traumatology, The Chinese University of Hong Kong, Hong Kong SAR, PR China.
| | - J Y Wang
- Department of Orthopaedics and Traumatology, The Chinese University of Hong Kong, Hong Kong SAR, PR China.
| | - J Yue
- Department of Orthopaedics and Traumatology, The Chinese University of Hong Kong, Hong Kong SAR, PR China.
| | - S H Yung
- Department of Orthopaedics and Traumatology, The Chinese University of Hong Kong, Hong Kong SAR, PR China.
| | - P J Hu
- Department of Biomedical Engineering, Polytechnic University of Hong Kong, Hong Kong SAR, PR China.
| | - Y C Ruan
- Department of Biomedical Engineering, Polytechnic University of Hong Kong, Hong Kong SAR, PR China.
| | - Y F Zhang
- School of Life Science and Technology, ShanghaiTech University, Shanghai, PR China.
| | - K W Ho
- Department of Orthopaedics and Traumatology, The Chinese University of Hong Kong, Hong Kong SAR, PR China.
| | - L Qin
- Department of Orthopaedics and Traumatology, The Chinese University of Hong Kong, Hong Kong SAR, PR China.
| |
Collapse
|
60
|
Sheng ZX, Yao H, Cai ZY. The role of miR-146b-5p in TLR4 pathway of glomerular mesangial cells with lupus nephritis. Eur Rev Med Pharmacol Sci 2019; 22:1737-1743. [PMID: 29630120 DOI: 10.26355/eurrev_201803_14589] [Citation(s) in RCA: 13] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
Abstract
OBJECTIVE MicroRNAs (miRNAs) are now recognized as important regulators of gene expression. The aim of the study was to investigate the role of miR-146b-5p in the TLR4 pathway and provide the basis for the treatment of lupus nephritis. MATERIALS AND METHODS The glomerular mesangial cells were cultured in vitro and divided into 3 groups: control group, a group of miR-146b-5p mimic added, and a group of miR-146b-5p inhibitor added. The levels of IL-6 and IL-8 in the cell culture supernatant of the three groups were detected by ELISA. The cell proliferation was detected by MTT. The expressions of MiR-146b-5p and TLR4 pathway-associated factor TRAF6 were detected by RT- PCR. The expression of TRAF6 and IRAK1 protein was detected by Western blot. RESULTS The overexpression of miR-146b-5p could reduce the level of IL6 and IL8 in cell culture and inhibit glomerular mesangial cell proliferation in some degree. Also, the overexpression of miR-146b-5p could inhibit the expressions of TLR4 pathway-associated factor TRAF6 and IRAK1mRNA, and the expressions of TRAF6 and IRAK1 protein. CONCLUSIONS MiR-146b-5p attenuated the inflammatory response of glomerular mesangial cells by inhibiting the expressions levels of TRAF6 and IRAK1 in lupus nephritis.
Collapse
Affiliation(s)
- Z-X Sheng
- Department of Renal Medicine, The Affiliated Yantai Yuhuangding Hospital of Qingdao University, Yantai, Shandong, China.
| | | | | |
Collapse
|
61
|
Sun H, Wang Y, Yao H, Wang L, Wu S, Si Y, Meng Y, Xu J, Wang Q, Sun X, Li Z. Retracted article: The clinical significance of serum sCD25 as a sensitive disease activity marker for rheumatoid arthritis. Scand J Rheumatol 2019; 48:505-509. [PMID: 31159626 DOI: 10.1080/03009742.2019.1574890] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
Affiliation(s)
- H Sun
- Department of Rheumatology and Immunology and Beijing Key Laboratory for Rheumatism and Immune Diagnosis (BZ0135), Peking University People's Hospital, Beijing, China.,Department of Rheumatology and Immunology, The Fifth Affiliated Hospital of Zhengzhou University, Zhengzhou, China
| | - Y Wang
- Department of Rheumatology and Immunology, The Fifth Affiliated Hospital of Zhengzhou University, Zhengzhou, China
| | - H Yao
- Department of Rheumatology and Immunology and Beijing Key Laboratory for Rheumatism and Immune Diagnosis (BZ0135), Peking University People's Hospital, Beijing, China
| | - L Wang
- Department of Rheumatology and Immunology, The Fifth Affiliated Hospital of Zhengzhou University, Zhengzhou, China
| | - S Wu
- Department of Rheumatology and Immunology, The Fifth Affiliated Hospital of Zhengzhou University, Zhengzhou, China
| | - Y Si
- Department of Rheumatology and Immunology, The Fifth Affiliated Hospital of Zhengzhou University, Zhengzhou, China
| | - Y Meng
- Department of Rheumatology and Immunology, The Fifth Affiliated Hospital of Zhengzhou University, Zhengzhou, China
| | - J Xu
- Department of Rheumatology and Immunology, The Fifth Affiliated Hospital of Zhengzhou University, Zhengzhou, China
| | - Q Wang
- Department of Rheumatology and Immunology, Peking University Shenzhen Hospital, Guangdong, China
| | - X Sun
- Department of Rheumatology and Immunology and Beijing Key Laboratory for Rheumatism and Immune Diagnosis (BZ0135), Peking University People's Hospital, Beijing, China
| | - Z Li
- Department of Rheumatology and Immunology and Beijing Key Laboratory for Rheumatism and Immune Diagnosis (BZ0135), Peking University People's Hospital, Beijing, China
| |
Collapse
|
62
|
Yu Y, Li A, Chen Y, Li Q, Ou Q, Lin D, Zhang W, Li Z, Hu H, Yao H. Association of survival and blood-based genomic signature with atezolizumab for patients with second-line and third-line EGFR wild-type non-small cell lung cancer: Pooled analysis of individual patient data from the POPLAR and OAK trials. Ann Oncol 2019. [DOI: 10.1093/annonc/mdz438] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/23/2022] Open
|
63
|
Wang CZ, Zhang CF, Luo Y, Yao H, Yu C, Chen L, Yuan J, Huang WH, Wan JY, Zeng J, Sawadogo WR, Yuan CS. Baicalein, an enteric microbial metabolite, suppresses gut inflammation and cancer progression in Apc Min/+ mice. Clin Transl Oncol 2019; 22:1013-1022. [PMID: 31650468 DOI: 10.1007/s12094-019-02225-5] [Citation(s) in RCA: 30] [Impact Index Per Article: 6.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/12/2019] [Accepted: 10/03/2019] [Indexed: 12/19/2022]
Abstract
OBJECTIVE Chronic inflammation is recognized as a risk factor for colorectal cancer (CRC) development. Baicalin (BI), a major constituent in an anti-inflammatory herb Scutellaria baicalensis, can be biotransformed into baicalein (BE) by the intestinal microbiota. We evaluated the anti-inflammation and anti-CRC effects of the metabolite BE. METHODS The in vitro biotransformation by human intestinal microbiota from BI into BE has been determined with HPLC. Using a gut-specific ApcMin/+ mouse model, the effects of oral BE on the life span, organ index, and tumor multiplicity were evaluated. The expressions of inflammatory cytokines were determined using ELISA. To verify the in vivo data, the anti-inflammatory and antiproliferative effects of BE were determined with an in vitro cell model. RESULTS HPLC analysis showed that BI was quickly transformed into BE by the intestinal microbiota. Oral BE (30 mg/kg/day) significantly increased the life span, from 125.2 to 218.4 days (P < 0.01%). BE treatment also decreased intestine index and increased spleen index. Compared with the model group, following BE treatment, tumor numbers were significantly reduced in the small intestine and colon (P < 0.01, P < 0.05, respectively). In the gut tissues, BE treatment significantly reduced inflammatory cytokine levels such as IL-1β, IL-2, IL-6, IL-10, G-CSF, and GM-CSF. In vitro data supported our in vivo results that the anti-CRC effects of BE were via the inhibition of gut inflammation and induction of cancer cell death. CONCLUSION Our results suggest that the parent compound BI can be quickly converted into its microbial metabolite BE, which has stronger bioactive effects than BI. Baicalein is an active chemopreventive metabolite for inflammatory associated CRC.
Collapse
Affiliation(s)
- C-Z Wang
- Tang Center for Herbal Medicine Research, Pritzker School of Medicine, University of Chicago, 5841 S. Maryland Ave., MC 4028, Chicago, IL, 60637, USA.
- Department of Anesthesia and Critical Care, Pritzker School of Medicine, University of Chicago, Chicago, IL, 60637, USA.
| | - C-F Zhang
- Tang Center for Herbal Medicine Research, Pritzker School of Medicine, University of Chicago, 5841 S. Maryland Ave., MC 4028, Chicago, IL, 60637, USA
- Department of Anesthesia and Critical Care, Pritzker School of Medicine, University of Chicago, Chicago, IL, 60637, USA
| | - Y Luo
- Tang Center for Herbal Medicine Research, Pritzker School of Medicine, University of Chicago, 5841 S. Maryland Ave., MC 4028, Chicago, IL, 60637, USA
- Department of Anesthesia and Critical Care, Pritzker School of Medicine, University of Chicago, Chicago, IL, 60637, USA
| | - H Yao
- Tang Center for Herbal Medicine Research, Pritzker School of Medicine, University of Chicago, 5841 S. Maryland Ave., MC 4028, Chicago, IL, 60637, USA
- Department of Anesthesia and Critical Care, Pritzker School of Medicine, University of Chicago, Chicago, IL, 60637, USA
| | - C Yu
- Tang Center for Herbal Medicine Research, Pritzker School of Medicine, University of Chicago, 5841 S. Maryland Ave., MC 4028, Chicago, IL, 60637, USA
- Department of Anesthesia and Critical Care, Pritzker School of Medicine, University of Chicago, Chicago, IL, 60637, USA
| | - L Chen
- Tang Center for Herbal Medicine Research, Pritzker School of Medicine, University of Chicago, 5841 S. Maryland Ave., MC 4028, Chicago, IL, 60637, USA
- Department of Anesthesia and Critical Care, Pritzker School of Medicine, University of Chicago, Chicago, IL, 60637, USA
| | - J Yuan
- Tang Center for Herbal Medicine Research, Pritzker School of Medicine, University of Chicago, 5841 S. Maryland Ave., MC 4028, Chicago, IL, 60637, USA
- Department of Anesthesia and Critical Care, Pritzker School of Medicine, University of Chicago, Chicago, IL, 60637, USA
| | - W-H Huang
- Tang Center for Herbal Medicine Research, Pritzker School of Medicine, University of Chicago, 5841 S. Maryland Ave., MC 4028, Chicago, IL, 60637, USA
- Department of Anesthesia and Critical Care, Pritzker School of Medicine, University of Chicago, Chicago, IL, 60637, USA
| | - J-Y Wan
- Tang Center for Herbal Medicine Research, Pritzker School of Medicine, University of Chicago, 5841 S. Maryland Ave., MC 4028, Chicago, IL, 60637, USA
- Department of Anesthesia and Critical Care, Pritzker School of Medicine, University of Chicago, Chicago, IL, 60637, USA
| | - J Zeng
- Tang Center for Herbal Medicine Research, Pritzker School of Medicine, University of Chicago, 5841 S. Maryland Ave., MC 4028, Chicago, IL, 60637, USA
- Department of Anesthesia and Critical Care, Pritzker School of Medicine, University of Chicago, Chicago, IL, 60637, USA
| | - W R Sawadogo
- Tang Center for Herbal Medicine Research, Pritzker School of Medicine, University of Chicago, 5841 S. Maryland Ave., MC 4028, Chicago, IL, 60637, USA
- Department of Anesthesia and Critical Care, Pritzker School of Medicine, University of Chicago, Chicago, IL, 60637, USA
| | - C-S Yuan
- Tang Center for Herbal Medicine Research, Pritzker School of Medicine, University of Chicago, 5841 S. Maryland Ave., MC 4028, Chicago, IL, 60637, USA
- Department of Anesthesia and Critical Care, Pritzker School of Medicine, University of Chicago, Chicago, IL, 60637, USA
- Committee on Clinical Pharmacology and Pharmacogenomics, Pritzker School of Medicine, University of Chicago, Chicago, IL, 60637, USA
| |
Collapse
|
64
|
Farnier M, Mouhat B, Pommier T, Yao H, Maza M, Chague F, Bichat F, Cottin Y, Zeller M. 2214Prevalence and severity of coronary disease in patients with familial hypercholesterolemia hospitalized for an acute myocardial infarction: data from the RICO survey. Eur Heart J 2019. [DOI: 10.1093/eurheartj/ehz748.0118] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Abstract
Abstract
Aim
Individuals with heterozygous familial hypercholesterolemia (FH) are at high risk of early myocardial infarction (MI). However, coronary artery disease (CAD) burden of FH remains not well described. From a large database of a regional registry of acute MI, we aimed to address prevalence of FH and severity of CAD.
Methods
Consecutive patients hospitalized with MI in a multicentre database from 2001–2017 were considered. An algorithm, adapted from Dutch Lipid Clinic Network criteria, was built upon 4 variables (LDL-cholesterol (LDL-C) and lipid lowering agents, premature and family history of CAD) to identify FH probabilities.
Results
Among the 11624 patients included in the survey, 249 (2.1%) had probable/definite FH (score ≥6), and 2405 (20.7%) had possible FH (score 3–5). When compared with patients without FH (score 0–2), FH patients (score ≥6) were 20y younger (51 (46–57) vs 71 (61–80) y, p<0.001), with a lower rate of hypertension (47 vs 59%, p<0.001), diabetes (17 vs 25%, p<0.001) and prior stroke (4 vs 8%, p=0.016), but a higher prevalence of smokers (56 vs 23%, p<0.001), personal (20 vs 15%, p=0.02) or familial history of CAD (78 vs 18%, p<0.001). Chronic statin treatment was only used in 48% of FH patients and ezetimibe in 8%. After adjustment for age, sex and diabetes, FH patients were characterized by increased extent of CAD (syntax score 11 (4–19) vs 7 (1–13), p<0.001) and multivessel disease (55 vs 40%, p<0.001).
Conclusion
In this large real world population of acute MI, a high prevalence of FH was found. FH patients were characterized by their young age associated with the severity of CAD burden and limited use of preventive lipid lowering therapy.
Acknowledgement/Funding
University Hospital Center Dijon Bourgogne, Agence Régionale de Santé Bourgogne Franche Comté, France
Collapse
Affiliation(s)
- M Farnier
- Point Médical, Lipid Clinic and, University Hospital Center Dijon Bourgogne, Cardiology Department, Dijon, France
| | - B Mouhat
- University Hospital Center Dijon Bourgogne, Cardiology Department, Dijon, France
| | - T Pommier
- University Hospital Center Dijon Bourgogne, Cardiology Department, Dijon, France
| | - H Yao
- University Hospital Center Dijon Bourgogne, Cardiology Department, Dijon, France
| | - M Maza
- University Hospital Center Dijon Bourgogne, Cardiology Department, Dijon, France
| | - F Chague
- University Hospital Center Dijon Bourgogne, Cardiology Department, Dijon, France
| | - F Bichat
- University Hospital Center Dijon Bourgogne, Cardiology Department, Dijon, France
| | - Y Cottin
- University Hospital Center Dijon Bourgogne, Cardiology Department, Dijon, France
| | - M Zeller
- Université de Bourgogne Franche Comté, PEC2, EA7460, Dijon, France
| |
Collapse
|
65
|
Farnier M, Mouhat B, Pommier T, Yao H, Maza M, Chagué F, Bichat F, Cottin Y, Zeller M. Prevalence And Severity Of Coronary Disease In Patients With Familial Hypercholesterolemia Hospitalized For An Acute Myocardial Infarction: Data From The Rico Survey. Atherosclerosis 2019. [DOI: 10.1016/j.atherosclerosis.2019.06.332] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
66
|
Wu Y, Cisewski SE, Coombs MC, Brown MH, Wei F, She X, Kern MJ, Gonzalez YM, Gallo LM, Colombo V, Iwasaki LR, Nickel JC, Yao H. Effect of Sustained Joint Loading on TMJ Disc Nutrient Environment. J Dent Res 2019; 98:888-895. [PMID: 31126205 DOI: 10.1177/0022034519851044] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/31/2022] Open
Abstract
The temporomandibular joint (TMJ) disc nutrient environment profoundly affects cell energy metabolism, proliferation, and biosynthesis. Due to technical challenges of in vivo measurements, the human TMJ disc extracellular nutrient environment under load, which depends on metabolic rates, solute diffusion, and disc morphometry, remains unknown. Therefore, the study objective was to predict the TMJ disc nutrient environment under loading conditions using combined experimental and computational modeling approaches. Specifically, glucose consumption and lactate production rates of porcine TMJ discs were measured under varying tissue culture conditions (n = 40 discs), and mechanical strain-dependent glucose and lactate diffusivities were measured using a custom diffusion chamber (n = 6 discs). TMJ anatomy and loading area were obtained from magnetic resonance imaging of healthy human volunteers (n = 11, male, 30 ± 9 y). Using experimentally determined nutrient metabolic rates, solute diffusivities, TMJ anatomy, and loading areas, subject-specific finite element (FE) models were developed to predict the 3-dimensional nutrient profiles in unloaded and loaded TMJ discs (unloaded, 0% strain, 20% strain). From the FE models, glucose, lactate, and oxygen concentration ranges for unloaded healthy human TMJ discs were 0.6 to 4.0 mM, 0.9 to 5.0 mM, and 0% to 6%, respectively, with steep gradients in the anterior and posterior bands. Sustained mechanical loading significantly reduced nutrient levels (P < 0.001), with a critical zone in which cells may die representing approximately 13.5% of the total disc volume. In conclusion, this study experimentally determined TMJ disc metabolic rates, solute diffusivities, and disc morphometry, and through subject-specific FE modeling, revealed critical interactions between mechanical loading and nutrient supply and metabolism for the in vivo human TMJ disc. The results suggest that TMJ disc homeostasis may be vulnerable to pathological loading (e.g., clenching, bruxism), which impedes nutrient supply. Given difficulties associated with direct in vivo measurements, this study provides a new approach to systematically investigate homeostatic and degenerative mechanisms associated with the TMJ disc.
Collapse
Affiliation(s)
- Y Wu
- 1 Department of Bioengineering, Clemson University, Clemson, SC, USA.,2 Department of Orthopaedics and Physical Medicine, Medical University of South Carolina (MUSC), Charleston, SC, USA
| | - S E Cisewski
- 1 Department of Bioengineering, Clemson University, Clemson, SC, USA.,3 Department of Oral Health Sciences, College of Dental Medicine, MUSC, Charleston, SC, USA
| | - M C Coombs
- 1 Department of Bioengineering, Clemson University, Clemson, SC, USA.,3 Department of Oral Health Sciences, College of Dental Medicine, MUSC, Charleston, SC, USA
| | - M H Brown
- 3 Department of Oral Health Sciences, College of Dental Medicine, MUSC, Charleston, SC, USA
| | - F Wei
- 1 Department of Bioengineering, Clemson University, Clemson, SC, USA
| | - X She
- 1 Department of Bioengineering, Clemson University, Clemson, SC, USA
| | - M J Kern
- 3 Department of Oral Health Sciences, College of Dental Medicine, MUSC, Charleston, SC, USA
| | - Y M Gonzalez
- 4 Department of Oral Diagnostic Sciences, School of Dental Medicine, University at Buffalo, Buffalo, NY, USA
| | - L M Gallo
- 5 Clinic of Masticatory Disorders, University of Zurich, School of Dental Medicine, Zurich, Switzerland
| | - V Colombo
- 5 Clinic of Masticatory Disorders, University of Zurich, School of Dental Medicine, Zurich, Switzerland
| | - L R Iwasaki
- 6 Department of Orthodontics, School of Dentistry, Oregon Health & Science University, Portland, OR, USA
| | - J C Nickel
- 6 Department of Orthodontics, School of Dentistry, Oregon Health & Science University, Portland, OR, USA
| | - H Yao
- 1 Department of Bioengineering, Clemson University, Clemson, SC, USA.,2 Department of Orthopaedics and Physical Medicine, Medical University of South Carolina (MUSC), Charleston, SC, USA.,3 Department of Oral Health Sciences, College of Dental Medicine, MUSC, Charleston, SC, USA
| |
Collapse
|
67
|
Li X, Guan L, Zilundu PLM, Chen J, Chen Z, Ma M, Zhuang H, Zhuang Z, Qiu Y, Ye F, Wu X, Sang H, Ye Y, Han Y, Yao H, Li H, Zhong G, Wu H, Jiang Z, Chu G, Xu D, Zhou L. The applied anatomy and clinical significance of the proximal, V1 segment of vertebral artery. Folia Morphol (Warsz) 2019; 78:710-719. [PMID: 30949997 DOI: 10.5603/fm.a2019.0039] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/31/2018] [Revised: 03/05/2019] [Accepted: 03/06/2019] [Indexed: 11/25/2022]
Abstract
BACKGROUND The aim of the study was to probe the morphological features of the proximal segment (V1) of vertebral artery (VA) in a sample of Chinese cadavers. MATERIALS AND METHODS The origin, course and outer diameter at origin of the pre-vertebral part of the VAs were evaluated in 119 adult cadavers. RESULTS It was found that 94.12% of the VAs originated from the subclavian arteries, bilaterally. The variant origins were present in 5.88% of the cadavers and all originated directly from the arch of the aorta. All the variations were observed on the left side of male cadavers. The average outer diameters at origin of the normal and variation groups were 4.35 ± 1.00 mm and 4.82 ± ± 1.42 mm, respectively, p = 0.035. In the normal group, but not in the variation group, the average diameter in the males was significantly larger than that in the females (4.50 ± 0.99 mm, 3.92 ± 0.92 mm, respectively, p = 0.000). In addition, only 5 cadavers in the normal group had hypoplastic VAs (4.20%, 4 males, 3 right-sided). Vertebral artery dominance (VAD) was present in 91 (69 males) out of 112 cadavers and more common on the left (n = 48). In addition, 3 cadavers satisfied conditions for coexistence of VAD and vertebral artery hypoplasia. All 7 cadavers in the variation group exhibited VAD, which was more common on the right side (n = 5). CONCLUSIONS The morphologic variations and frequencies described above have implications for the early prevention, abnormal anatomy detection, accurate diagnosis, safe surgery and endovascular treatment of cardiovascular and neurological disease.
Collapse
Affiliation(s)
- X Li
- Department of Human Anatomy, Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou City, Guangdong Province, China
| | - L Guan
- Department of Human Anatomy, Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou City, Guangdong Province, China
| | - Prince L M Zilundu
- Department of Human Anatomy, Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou City, Guangdong Province, China
| | - J Chen
- Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou City, Guangdong Province, China
| | - Z Chen
- Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou City, Guangdong Province, China
| | - M Ma
- Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou City, Guangdong Province, China
| | - H Zhuang
- Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou City, Guangdong Province, China
| | - Z Zhuang
- Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou City, Guangdong Province, China
| | - Y Qiu
- Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou City, Guangdong Province, China
| | - F Ye
- Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou City, Guangdong Province, China
| | - X Wu
- Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou City, Guangdong Province, China
| | - H Sang
- Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou City, Guangdong Province, China
| | - Y Ye
- Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou City, Guangdong Province, China
| | - Y Han
- Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou City, Guangdong Province, China
| | - H Yao
- Department of Human Anatomy, Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou City, Guangdong Province, China
| | - H Li
- Department of Human Anatomy, Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou City, Guangdong Province, China
| | - G Zhong
- Department of Human Anatomy, Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou City, Guangdong Province, China
| | - H Wu
- Department of Human Anatomy, Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou City, Guangdong Province, China
| | - Z Jiang
- Department of Human Anatomy, Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou City, Guangdong Province, China
| | - G Chu
- Department of Human Anatomy, Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou City, Guangdong Province, China
| | - D Xu
- Department of Human Anatomy, Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou City, Guangdong Province, China.
| | - L Zhou
- Department of Human Anatomy, Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou City, Guangdong Province, China.,Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou City, Guangdong Province, China
| |
Collapse
|
68
|
Yao H, Zheng D, Xie M, Wang Z. 268 A New Look at Reconstruction Strategy: Classification and Management for Extramammary Paget's Disease. J Sex Med 2019. [DOI: 10.1016/j.jsxm.2019.01.274] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
69
|
Yang Y, Huang AM, Wang YN, Zhang L, Li FY, Yao H, Yan P. [Study on the correlation between work-related musculoskeletal disorders and work ability among nurses at three level general hospital in Xinjiang]. Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi 2019; 36:669-673. [PMID: 30419669 DOI: 10.3760/cma.j.issn.1001-9391.2018.09.006] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Abstract
Objective: To investigate the correlation between work-related musculoskeletal disorders (WMSDs) and work ability (WA) among nurses in Xinjiang. Methods: A total of 1 873 nursing staff in the Departments of Internal Medicine, Surgery, Emergency and ICU Department, Operating Room and Supply Room of 6 Grade 3 General Hospitals in Xinjiang Beijiang Region were randomly selected by means of random sampling, and revised Nordic National Musculoskeletal Disorders Standard Questionnaire and Work Ability Index Scale were used to evaluate the status of nursing WMSDs and WA. Results: (1) The symptom incidence of work-related musculoskeletal disorders among nursing staff in the past year was 77.42%; The highest symptom incidence in all parts of the body was waist, neck, shoulder and back, and the symptom incidence was 63.59%, 59.80%, 47.78% and 37.32%, respectively; (2) The total score of nursing staff's work ability was (35.91±5.143) ; The proportion of "poor" , "middle" , "good" and "excellent" were 5.23%, 47.41%, 41.43% and 5.93% respectively; (3) The total working capacity of the sick group was (35.11±5.044) , The working ability of the non-diseased group was (38.64±4.507) , The difference between the two groups was statistically significant (t=13.773, P<0.01) ; There was a significant difference in the level of work ability between the two groups (z=-12.335, P<0.01) ; The working ability of "poor" and medium in the injury group was significantly higher than that of the non injury group, while the working ability was "better" and "excellent" than that of the non injury group; (4) The working ability of nursing staff of different age in WMSDs injury group was lower than that in non injury group, the difference was statistically significant (P<0.01) ; There was a negative correlation between the working ability of the injury group and the length of service, that is, with the increase of the length of service, the working ability index decreased (P<0.01) ; There was a positive correlation between the working ability of the non injury group and the length of service, that is, with the increase of the length of service, the work ability index increased gradually, but the correlation was not statistically significant (r=0.063, P=0.195) ; (5) The working ability of nursing staff of different departments in WMSDs injury group was lower than that in non injury group, the difference was statistically significant (P<0.01) . (6) Multiple linear regression analysis showed that the factors influencing the working ability of nursing staff were: past medical history, WMSDs disease, length of service and night shift frequency; Conclusion: The symptom incidence of WMSDs was high among nurses; Work Ability at a moderate level; work-related musculoskeletal disorders is associated with reduced ability of nursing staff; work-related musculoskeletal disorders are associated with reduced working capacity of nursing staff.
Collapse
Affiliation(s)
- Y Yang
- The First Affiliated Hospital of Xinjiang Medical University, Urumqi 830054, China
| | | | | | | | | | | | | |
Collapse
|
70
|
Wang J, Chen W, Jiang Z, Lin X, Qin T, Yang X, Liu T, Hu H, Li Z, Xie D, Yao H, Song E. Abstract P4-04-11: A small amount of primary breast cancer shows high tumor mutation burden that may benefit from immune checkpoint inhibitor therapy. Cancer Res 2019. [DOI: 10.1158/1538-7445.sabcs18-p4-04-11] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Abstract
Background: Targeted therapy using immune checkpoint inhibitors (ICIs) is a major breakthrough in cancer treatment in the last decade. ICIs like PD1 or PD-L1 antibodies have been shown to be quite effective in cancer like melanoma. However, in most other tumor types including breast cancer, the situation is not as optimistic. Only a small percentage of those patients respond to ICIs therapy. This highlights the importance of identifying biomarkers to predict which patients may benefit from such treatment. Tumor Mutation Burden (TMB) has been shown to be a sensitive marker for ICI treatment. This study is to investigate whether TBM could be used as a biomarker for breast cancer treatment.
Methods: We reviewed next generation sequencing studies of breast cancer. Two such studies with raw data provided were included in our analysis. One study entitled METABRIC performed targeted sequencing of 173 cancer-related genes in around 2500 primary breast cancer tissues. The other study was from TCGA breast cancer project, which performed Whole Exome Sequencing (WES) of around 1000 primary breast cancer samples. Mutation data were downloaded from public data deposit. The number of mutations per sample was calculated. TBM was calculated by divide the coverage in million base pair from that of the total mutation counts.
Results: In METABRIC study, 17272 mutations were identified in 2369 samples, with a median of 7 mutations per sample (95% CI: 6 ˜ 7). The median TMB of METABRIC dataset was 5.8 SNVs/Mb (95% CI: 5 ˜ 5.8). Totally 30 out 2369 (1.3%) samples had a TMB equal or large than 20 SNVs/Mb. In another cohort from TCGA breast cancer study using WES technology, 90172 mutations were identified in 977 samples, with a median of 44 mutations per sample (95% CI: 39 ˜ 50). The median TMB was 1 SNVs/Mb (95% CI: 0.9 ˜ 1.1). Totally 13 out 977 (1.3%) samples had a TMB equal or large than 20 SNVs/Mb.
Conclusions: Breast cancer shows middle to low mutation burden compared to other cancer types. Around 1.3% of breast cancer has quite high TMB of at least 20 SNVs/Mb, which may be qualified for immune checkpoint inhibitors therapy. Our study indicates that TMB may be incorporated as a standard test for late stage breast cancer patients in the clinical practice.
Keywords: Breast cancer, Tumor Mutation Burden, Whole exome sequencing, Targeted sequencing, Immune checkpoint
Citation Format: Wang J, Chen W, Jiang Z, Lin X, Qin T, Yang X, Liu T, Hu H, Li Z, Xie D, Yao H, Song E. A small amount of primary breast cancer shows high tumor mutation burden that may benefit from immune checkpoint inhibitor therapy [abstract]. In: Proceedings of the 2018 San Antonio Breast Cancer Symposium; 2018 Dec 4-8; San Antonio, TX. Philadelphia (PA): AACR; Cancer Res 2019;79(4 Suppl):Abstract nr P4-04-11.
Collapse
Affiliation(s)
- J Wang
- Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China; The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China
| | - W Chen
- Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China; The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China
| | - Z Jiang
- Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China; The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China
| | - X Lin
- Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China; The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China
| | - T Qin
- Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China; The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China
| | - X Yang
- Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China; The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China
| | - T Liu
- Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China; The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China
| | - H Hu
- Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China; The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China
| | - Z Li
- Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China; The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China
| | - D Xie
- Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China; The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China
| | - H Yao
- Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China; The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China
| | - E Song
- Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China; The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China
| |
Collapse
|
71
|
Song E, Chao X, Nie Y, Jin X, Tan C, Cui J, Hu H, Yao H. Abstract P4-08-32: Derivation and validation of a novel prediction model in breast phyllodes tumors after surgery. Cancer Res 2019. [DOI: 10.1158/1538-7445.sabcs18-p4-08-32] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Abstract
Aim
This study aimed to develop a nomogram based on clinicopathological features to evaluate the recurrence probability of breast phyllodes tumors following surgery. The criteria for atypia, mitoses, overgrowth, and surgical margin (AMOS) were also validated.
Method
Data from 334 patients with breast phyllodes tumors, who underwent surgical treatment at Sun Yat-sen Memorial Hospital from January 2005 to December 2014, were used to develop a prediction model. Additionally, data of 36 patients from Peking University Shenzhen Hospital and data of 140 patients from Sun Yat-sen University Cancer Center during the same period were used to validate the model. The medical records and tumor slides were retrospectively reviewed. The log-rank and Cox regression tests were used to develop a clinical prediction model of breast phyllodes tumors as well as validating the AMOS criteriaAll statistical analyses were performed using R and STATA.
Results
Of all 334 patients included in the study, 224 had benign, 91 had borderline, and 19 had malignant tumors. The local and distant recurrence rate was 17.7%. The 1-,3-, and 5-year cumulative recurrence-free survival was 98.5%, 97.9%, and 96.8%, respectively. Surgical margin, mitoses, and tumor border were identified as independent risk factors for breast phyllodes tumors. A nomogram was developed based on these three variables. The C-index of internal and external validation was 0.71and 0.67, respectively. The area under the curve of AMOS criteria was 0.59.
Conclusions
The present study model presented a more concise and objective variables to evaluate the recurrence-free survival of patients after surgery compared with that using the AMOS criteria, which is more appropriate for clinical practice and also allows for a more accurate prediction.
Citation Format: Song E, Chao X, Nie Y, Jin X, Tan C, Cui J, Hu H, Yao H. Derivation and validation of a novel prediction model in breast phyllodes tumors after surgery [abstract]. In: Proceedings of the 2018 San Antonio Breast Cancer Symposium; 2018 Dec 4-8; San Antonio, TX. Philadelphia (PA): AACR; Cancer Res 2019;79(4 Suppl):Abstract nr P4-08-32.
Collapse
Affiliation(s)
- E Song
- Sun Yat-sen Memorial Hospital, Guangzhou, Guangdong, China; Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, China; Peking University Shenzhen Hospital, Shenzhen, Guangdong, China
| | - X Chao
- Sun Yat-sen Memorial Hospital, Guangzhou, Guangdong, China; Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, China; Peking University Shenzhen Hospital, Shenzhen, Guangdong, China
| | - Y Nie
- Sun Yat-sen Memorial Hospital, Guangzhou, Guangdong, China; Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, China; Peking University Shenzhen Hospital, Shenzhen, Guangdong, China
| | - X Jin
- Sun Yat-sen Memorial Hospital, Guangzhou, Guangdong, China; Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, China; Peking University Shenzhen Hospital, Shenzhen, Guangdong, China
| | - C Tan
- Sun Yat-sen Memorial Hospital, Guangzhou, Guangdong, China; Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, China; Peking University Shenzhen Hospital, Shenzhen, Guangdong, China
| | - J Cui
- Sun Yat-sen Memorial Hospital, Guangzhou, Guangdong, China; Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, China; Peking University Shenzhen Hospital, Shenzhen, Guangdong, China
| | - H Hu
- Sun Yat-sen Memorial Hospital, Guangzhou, Guangdong, China; Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, China; Peking University Shenzhen Hospital, Shenzhen, Guangdong, China
| | - H Yao
- Sun Yat-sen Memorial Hospital, Guangzhou, Guangdong, China; Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, China; Peking University Shenzhen Hospital, Shenzhen, Guangdong, China
| |
Collapse
|
72
|
Song E, Yao H, Yu Y, Ou Q, Wang Y. Abstract P1-16-07: Progression-free survival is a surrogate of survival in maintenance therapy for metastatic breast cancer: Randomized trial level analysis. Cancer Res 2019. [DOI: 10.1158/1538-7445.sabcs18-p1-16-07] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Abstract
Background:The validity of progression-free survival (PFS) as a surrogate end point for overall survival (OS) in maintenance therapy trials of metastatic breast cancer (MBC) is uncertain. We aimed to compare treatment effect sizes and the strength of associations between OS and PFS in trials of maintenance therapy for MBC.
Methods: We searched for randomized trials investigating maintenance chemotherapy, endocrine therapy or immunotherapy after first-line chemotherapy in MBC and selected those reporting results for both OS and PFS. Treatment effect size differences between OS and PFS by a ratio of hazard ratios (rHRs) with 95% confidence intervals [CIs] were evaluated using random effects analysis. Surrogacy were analyzed using a weighted linear regression model, correlations were evaluated by squared correlation R2.
Results: We analyzed data from 16 trials and 3,898 patients that received maintenance chemotherapy, endocrine therapy or immunotherapy for MBC. In the all trial-level analysis, treatment effect sizes were 28% greater for PFS than for OS (combined rHR, 0.72; 95% CI, 0.62 to 0.85, P < 0.001), and the correlation coefficient R2 between PFS and OS was 18% (95% CI, 12% to 26%). Differences were greater with PFS than OS for trials of maintenance chemotherapy compared with observation (rHR, 0.72; 95% CI, 0.59 to 0.80, P < 0.001), and the correlation coefficient R2between treatment effects on PFS and on OS ranged from 12% (95% CI, 8% to 16%) when all trials were considered to 40% (95%CI, 30% to 54%) after exclusion of one highly influential trial by sensitivity analysis. Differences were also great for trials of maintenance endocrine therapy vs. observation (rHR, 0.54; 95% CI, 0.44 to 0.66), and immunotherapy vs. observation (rHR, 0.85; 95% CI, 0.80 to 0.91).
Conclusion: PFS was greater than OS in the treatment effect sizes, which is a valid surrogate end point for OS to assess treatment effect in MBC maintenance therapy trials.
PROSPERO registry: No. CRD42017071858; Support: ChiCTR-IIR-17014036, SYS-C-201801.
Citation Format: Song E, Yao H, Yu Y, Ou Q, Wang Y. Progression-free survival is a surrogate of survival in maintenance therapy for metastatic breast cancer: Randomized trial level analysis [abstract]. In: Proceedings of the 2018 San Antonio Breast Cancer Symposium; 2018 Dec 4-8; San Antonio, TX. Philadelphia (PA): AACR; Cancer Res 2019;79(4 Suppl):Abstract nr P1-16-07.
Collapse
Affiliation(s)
- E Song
- Breast Tumor Center, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China; Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China
| | - H Yao
- Breast Tumor Center, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China; Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China
| | - Y Yu
- Breast Tumor Center, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China; Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China
| | - Q Ou
- Breast Tumor Center, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China; Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China
| | - Y Wang
- Breast Tumor Center, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China; Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China
| |
Collapse
|
73
|
Yao H, Wu W, Ding L, Yu Y, Wang Y, Zeng Y, Zhao J, Li Q. Abstract OT2-05-01: FAMILY: A randomized, multicenter, open-label, phase III trial of fulvestrant versus capecitabine as maintenance therapy after first-line combination chemotherapy in patients with hormone receptor-positive, human epidermal growth factor receptor-2 negative metastatic breast cancer. Cancer Res 2019. [DOI: 10.1158/1538-7445.sabcs18-ot2-05-01] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Abstract
Background: Metastatic breast cancer (MBC) is incurable. Although first-line endocrine therapy is preferred to hormone receptor positive (HR+), human epidermal growth factor receptor-2 negative (HER2-) MBC, combination chemotherapy should be reserved as the initial treatment for patients with rapid clinical progression, life-threatening visceral metastases, and need for rapidly symptom control. Either prolonged chemotherapy or endocrine therapy may be used as maintenance after disease control. However, which maintenance strategy is superior in terms of delaying disease progression as well as maintaining quality of life (QOL) remains uncertain. This phase III trial aims to compare the efficacy and safety of fulvestrant or capecitabine as maintenance therapy after first-line combined chemotherapy in HR+/HER2- MBC.
Trial Design: FAMILY is a multicenter, randomized, open-label phase III trial for HR+ and HER2- MBC. Eligible participants are randomized (1:1) to receive capecitabine (2000mg/m2 twice daily x 14 days followed by 7 days off) or fulvestrant (500mg Days 0, 14, 28, then every 28 days) until disease progression, unacceptable toxicity, or patient refusal. Stratification factor for randomization is sensitivity to adjuvant hormonal therapy (disease-free interval ≤24 months vs. >24 months).
Eligibility Criteria: Eligible patients must have HR+ (ER and/or PR>1%, by IHC) and HER2- MBC; achieved a complete or partial response or stable disease (investigator assessed) after 4-8 cycles of first-line combination chemotherapy. Patients with central nervous system metastasis and/or prior use of endocrine therapy for advanced breast cancer are excluded.
Specific Aims: The primary endpoint is progression free survival (PFS). Secondary endpoints include overall survival, overall response rate, disease control rate, safety and QOL. A prospective translational research is also planned to assess the correlations between biomarkers and response.
Statistical Design: The planned sample size of 256 patients provides approximately 80% of power to detect a 6 months difference of PFS using a log-rank test with two-sided alpha of 0.05.
Target Accrual: Recruitment is ongoing. Up to 256 evaluable subjects will be enrolled within 24 months. (ChiCTR-IIR-17014036).
Citation Format: Yao H, Wu W, Ding L, Yu Y, Wang Y, Zeng Y, Zhao J, Li Q. FAMILY: A randomized, multicenter, open-label, phase III trial of fulvestrant versus capecitabine as maintenance therapy after first-line combination chemotherapy in patients with hormone receptor-positive, human epidermal growth factor receptor-2 negative metastatic breast cancer [abstract]. In: Proceedings of the 2018 San Antonio Breast Cancer Symposium; 2018 Dec 4-8; San Antonio, TX. Philadelphia (PA): AACR; Cancer Res 2019;79(4 Suppl):Abstract nr OT2-05-01.
Collapse
Affiliation(s)
- H Yao
- Breast Tumor Center, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China; Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China
| | - W Wu
- Breast Tumor Center, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China; Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China
| | - L Ding
- Breast Tumor Center, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China; Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China
| | - Y Yu
- Breast Tumor Center, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China; Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China
| | - Y Wang
- Breast Tumor Center, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China; Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China
| | - Y Zeng
- Breast Tumor Center, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China; Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China
| | - J Zhao
- Breast Tumor Center, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China; Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China
| | - Q Li
- Breast Tumor Center, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China; Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China
| |
Collapse
|
74
|
Benalia M, Zeller M, Mouhat B, Guenancia C, Yameogo V, Greco C, Yao H, Maza M, Vergès B, Cottin Y. Glycaemic variability is associated with severity of coronary artery disease in patients with poorly controlled type 2 diabetes and acute myocardial infarction. Diabetes Metab 2019; 45:446-452. [PMID: 30763700 DOI: 10.1016/j.diabet.2019.01.012] [Citation(s) in RCA: 19] [Impact Index Per Article: 3.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 07/31/2018] [Revised: 01/09/2019] [Accepted: 01/30/2019] [Indexed: 12/14/2022]
Abstract
BACKGROUND In patients with type 2 diabetes (T2D), glycaemic variability (GV), another component of glycaemic abnormalities, is a novel potentially aggravating factor for coronary artery disease (CAD). OBJECTIVES The aim of our study was to identify interactions between GV and severity of CAD in diabetes patients admitted for acute myocardial infarction (AMI). METHODS All patients with T2D admitted to our university hospital for AMI from March 2015 to February 2017 who received intravenous (IV) insulin therapy and underwent coronary angiography were included. GV was assessed by mean amplitude of blood glucose excursion (MAGE) values taken within 2 days of admission. Patients with higher GV (highest MAGE tertile) were compared with those with lower GV (first and second MAGE tertiles). RESULTS A total of 204 patients were included: median age was 72 (61-81) years; 32% were female; HbA1c was 7.3% (6.4-8.2%); diabetes duration was 10 (2-17.5) years; and MAGE value was 0.65 (0.43-0.92) g/L. Compared with those with lower GV, patients with the highest GV were more often women, treated with previous insulin, and had higher blood glucose and HbA1c levels. In addition, patients with elevated GV had significantly higher SYNTAX scores: 17 (10-28) vs. 12 (6-22) (P = 0.009). Indeed, SYNTAX scores (OR: 1.05, 95% CI: 1.02-1.08; P = 0.001) remained independently associated with high GV beyond HbA1c levels (OR: 1.51, 95% CI: 1.2-1.89; P < 0.001). CONCLUSION In AMI patients with poorly controlled diabetes, GV is associated with CAD severity beyond chronic hyperglycaemia. Although no causality can be determined from our observational study, the results suggest that, in AMI, early evaluation of GV might contribute to the identification of those diabetes patients at high risk, and serve as a therapeutic target for both primary and secondary prevention.
Collapse
Affiliation(s)
- M Benalia
- Cardiology Department, University Hospital Center, 21000 Dijon Bourgogne, France
| | - M Zeller
- Physiopathology and Epidemiology Cerebro-Cardiovascular (PEC2), EA 7460 University of Bourgogne Franche-Comté, 21000 Dijon, France.
| | - B Mouhat
- Cardiology Department, University Hospital Center, 21000 Dijon Bourgogne, France
| | - C Guenancia
- Cardiology Department, University Hospital Center, 21000 Dijon Bourgogne, France
| | - V Yameogo
- Cardiology Department, University Hospital Center Yalgado Ouédraogo, 21000 Ouagadougou, Burkina Faso
| | - C Greco
- Cardiology Department, University Hospital Center, 21000 Dijon Bourgogne, France; Physiopathology and Epidemiology Cerebro-Cardiovascular (PEC2), EA 7460 University of Bourgogne Franche-Comté, 21000 Dijon, France
| | - H Yao
- Cardiology Department, University Hospital Center, 21000 Dijon Bourgogne, France
| | - M Maza
- Cardiology Department, University Hospital Center, 21000 Dijon Bourgogne, France
| | - B Vergès
- Endocrinology Department, University Hospital Center, 21000 Dijon Bourgogne, France
| | - Y Cottin
- Cardiology Department, University Hospital Center, 21000 Dijon Bourgogne, France
| |
Collapse
|
75
|
Armstrong W, Kang H, Liyanage A, Maxwell J, Mulholland J, Ndukum L, Ahmidouch A, Albayrak I, Asaturyan A, Ates O, Baghdasaryan H, Boeglin W, Bosted P, Brash E, Butuceanu C, Bychkov M, Carter P, Chen C, Chen JP, Choi S, Christy ME, Covrig S, Crabb D, Danagoulian S, Daniel A, Davidenko AM, Davis B, Day D, Deconinck W, Deur A, Dunne J, Dutta D, El Fassi L, Ellis C, Ent R, Flay D, Frlez E, Gaskell D, Geagla O, German J, Gilman R, Gogami T, Gomez J, Goncharenko YM, Hashimoto O, Higinbotham D, Horn T, Huber GM, Jones M, Jones MK, Kalantarians N, Kang HK, Kawama D, Keith C, Keppel C, Khandaker M, Kim Y, King PM, Kohl M, Kovacs K, Kubarovsky V, Li Y, Liyanage N, Luo W, Mack D, Mamyan V, Markowitz P, Maruta T, Meekins D, Melnik YM, Meziani ZE, Mkrtchyan A, Mkrtchyan H, Mochalov VV, Monaghan P, Narayan A, Nakamura SN, Nuruzzaman A, Pentchev L, Pocanic D, Posik M, Puckett A, Qiu X, Reinhold J, Riordan S, Roche J, Rondón OA, Sawatzky B, Shabestari M, Slifer K, Smith G, Soloviev LF, Solvignon P, Tadevosyan V, Tang L, Vasiliev AN, Veilleux M, Walton T, Wesselmann F, Wood S, Yao H, Ye Z, Zhang J, Zhu L. Revealing Color Forces with Transverse Polarized Electron Scattering. Phys Rev Lett 2019; 122:022002. [PMID: 30720291 DOI: 10.1103/physrevlett.122.022002] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 05/28/2018] [Revised: 10/18/2018] [Indexed: 06/09/2023]
Abstract
The Spin Asymmetries of the Nucleon Experiment measured two double spin asymmetries using a polarized proton target and polarized electron beam at two beam energies, 4.7 and 5.9 GeV. A large-acceptance open-configuration detector package identified scattered electrons at 40° and covered a wide range in Bjorken x (0.3<x<0.8). Proportional to an average color Lorentz force, the twist-3 matrix element, d[over ˜]_{2}^{p}, was extracted from the measured asymmetries at Q^{2} values ranging from 2.0 to 6.0 GeV^{2}. The data display the opposite sign compared to most quark models, including the lattice QCD result, and an unexpected scale dependence. Furthermore, when combined with the neutron data in the same Q^{2} range the results suggest a flavor independent average color Lorentz force.
Collapse
Affiliation(s)
- W Armstrong
- Temple University, Philadelphia, Pennsylvania 19122, USA
- Argonne National Laboratory, Argonne, Illinois 60439, USA
| | - H Kang
- Seoul National University, Seoul, South Korea
| | - A Liyanage
- Hampton University, Hampton, Virginia 23669, USA
| | - J Maxwell
- University of Virginia, Charlottesville, Virginia 22904, USA
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - J Mulholland
- University of Virginia, Charlottesville, Virginia 22904, USA
| | - L Ndukum
- Mississippi State University, Starkville, Mississippi 39759, USA
| | - A Ahmidouch
- North Carolina A&M State University, Greensboro, North Carolina 27411, USA
| | - I Albayrak
- Hampton University, Hampton, Virginia 23669, USA
| | - A Asaturyan
- Yerevan Physics Institute, 0036, Yerevan, Armenia
| | - O Ates
- Hampton University, Hampton, Virginia 23669, USA
| | - H Baghdasaryan
- University of Virginia, Charlottesville, Virginia 22904, USA
| | - W Boeglin
- Florida International University, Miami, Florida 33199, USA
| | - P Bosted
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - E Brash
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
- Christopher Newport University, Newport News, Virginia 23606, USA
| | - C Butuceanu
- University of Regina, Regina, Saskatchewan, S4S 0A2, Canada
| | - M Bychkov
- University of Virginia, Charlottesville, Virginia 22904, USA
| | - P Carter
- Christopher Newport University, Newport News, Virginia 23606, USA
| | - C Chen
- Hampton University, Hampton, Virginia 23669, USA
| | - J-P Chen
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - S Choi
- Seoul National University, Seoul, South Korea
| | - M E Christy
- Hampton University, Hampton, Virginia 23669, USA
| | - S Covrig
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - D Crabb
- University of Virginia, Charlottesville, Virginia 22904, USA
| | - S Danagoulian
- North Carolina A&M State University, Greensboro, North Carolina 27411, USA
| | - A Daniel
- Ohio University, Athens, Ohio 45701, USA
| | - A M Davidenko
- Kurchatov Institute-IHEP, Protvino, Moskva 123098, Russia
| | - B Davis
- North Carolina A&M State University, Greensboro, North Carolina 27411, USA
| | - D Day
- University of Virginia, Charlottesville, Virginia 22904, USA
| | - W Deconinck
- William & Mary, Williamsburg, Virginia 23185, USA
| | - A Deur
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - J Dunne
- Mississippi State University, Starkville, Mississippi 39759, USA
| | - D Dutta
- Mississippi State University, Starkville, Mississippi 39759, USA
| | - L El Fassi
- Mississippi State University, Starkville, Mississippi 39759, USA
- Rutgers University, New Brunswick, New Jersey 08901, USA
| | - C Ellis
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - R Ent
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - D Flay
- Temple University, Philadelphia, Pennsylvania 19122, USA
| | - E Frlez
- University of Virginia, Charlottesville, Virginia 22904, USA
| | - D Gaskell
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - O Geagla
- University of Virginia, Charlottesville, Virginia 22904, USA
| | - J German
- North Carolina A&M State University, Greensboro, North Carolina 27411, USA
| | - R Gilman
- Rutgers University, New Brunswick, New Jersey 08901, USA
| | - T Gogami
- Tohoku University, Tohoku, Miyagi Prefecture 980-8577, Japan
| | - J Gomez
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | | | - O Hashimoto
- Tohoku University, Tohoku, Miyagi Prefecture 980-8577, Japan
| | - D Higinbotham
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - T Horn
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - G M Huber
- University of Regina, Regina, Saskatchewan, S4S 0A2, Canada
| | - M Jones
- North Carolina A&M State University, Greensboro, North Carolina 27411, USA
| | - M K Jones
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - N Kalantarians
- University of Virginia, Charlottesville, Virginia 22904, USA
- Virginia Union University, Richmond, Virginia 23220, USA
| | - H-K Kang
- Seoul National University, Seoul, South Korea
| | - D Kawama
- Tohoku University, Tohoku, Miyagi Prefecture 980-8577, Japan
| | - C Keith
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - C Keppel
- Hampton University, Hampton, Virginia 23669, USA
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - M Khandaker
- Norfolk State University, Norfolk, Virginia 23504, USA
| | - Y Kim
- Seoul National University, Seoul, South Korea
| | - P M King
- Ohio University, Athens, Ohio 45701, USA
| | - M Kohl
- Hampton University, Hampton, Virginia 23669, USA
| | - K Kovacs
- University of Virginia, Charlottesville, Virginia 22904, USA
| | - V Kubarovsky
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
- Rensselaer Polytechnic Institute, Troy, New York 12180, USA
| | - Y Li
- Hampton University, Hampton, Virginia 23669, USA
| | - N Liyanage
- University of Virginia, Charlottesville, Virginia 22904, USA
| | - W Luo
- Lanzhou University, Lanzhou, Gansu Sheng, China
| | - D Mack
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - V Mamyan
- University of Virginia, Charlottesville, Virginia 22904, USA
| | - P Markowitz
- Florida International University, Miami, Florida 33199, USA
| | - T Maruta
- Tohoku University, Tohoku, Miyagi Prefecture 980-8577, Japan
| | - D Meekins
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - Y M Melnik
- Kurchatov Institute-IHEP, Protvino, Moskva 123098, Russia
| | - Z-E Meziani
- Temple University, Philadelphia, Pennsylvania 19122, USA
| | - A Mkrtchyan
- Yerevan Physics Institute, 0036, Yerevan, Armenia
| | - H Mkrtchyan
- Yerevan Physics Institute, 0036, Yerevan, Armenia
| | - V V Mochalov
- Kurchatov Institute-IHEP, Protvino, Moskva 123098, Russia
| | - P Monaghan
- Hampton University, Hampton, Virginia 23669, USA
| | - A Narayan
- Mississippi State University, Starkville, Mississippi 39759, USA
| | - S N Nakamura
- Tohoku University, Tohoku, Miyagi Prefecture 980-8577, Japan
| | - A Nuruzzaman
- Mississippi State University, Starkville, Mississippi 39759, USA
| | - L Pentchev
- William & Mary, Williamsburg, Virginia 23185, USA
| | - D Pocanic
- University of Virginia, Charlottesville, Virginia 22904, USA
| | - M Posik
- Temple University, Philadelphia, Pennsylvania 19122, USA
| | - A Puckett
- University of Connecticut, Storrs, Connecticut 06269, USA
| | - X Qiu
- Hampton University, Hampton, Virginia 23669, USA
| | - J Reinhold
- Florida International University, Miami, Florida 33199, USA
| | - S Riordan
- University of Virginia, Charlottesville, Virginia 22904, USA
| | - J Roche
- Ohio University, Athens, Ohio 45701, USA
| | - O A Rondón
- University of Virginia, Charlottesville, Virginia 22904, USA
| | - B Sawatzky
- Temple University, Philadelphia, Pennsylvania 19122, USA
| | - M Shabestari
- University of Virginia, Charlottesville, Virginia 22904, USA
- Mississippi State University, Starkville, Mississippi 39759, USA
| | - K Slifer
- University of New Hampshire, Durham, New Hampshire 03824, USA
| | - G Smith
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - L F Soloviev
- Kurchatov Institute-IHEP, Protvino, Moskva 123098, Russia
| | - P Solvignon
- Argonne National Laboratory, Argonne, Illinois 60439, USA
| | - V Tadevosyan
- Yerevan Physics Institute, 0036, Yerevan, Armenia
| | - L Tang
- Hampton University, Hampton, Virginia 23669, USA
| | - A N Vasiliev
- Kurchatov Institute-IHEP, Protvino, Moskva 123098, Russia
| | - M Veilleux
- Christopher Newport University, Newport News, Virginia 23606, USA
| | - T Walton
- Hampton University, Hampton, Virginia 23669, USA
| | - F Wesselmann
- Xavier University, New Orleans, Louisiana 70125, USA
| | - S Wood
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - H Yao
- Temple University, Philadelphia, Pennsylvania 19122, USA
| | - Z Ye
- Hampton University, Hampton, Virginia 23669, USA
| | - J Zhang
- University of Virginia, Charlottesville, Virginia 22904, USA
| | - L Zhu
- Hampton University, Hampton, Virginia 23669, USA
| |
Collapse
|
76
|
Ashenfelter J, Balantekin AB, Baldenegro C, Band HR, Bass CD, Bergeron DE, Berish D, Bignell LJ, Bowden NS, Bricco J, Brodsky JP, Bryan CD, Bykadorova Telles A, Cherwinka JJ, Classen T, Commeford K, Conant AJ, Cox AA, Davee D, Dean D, Deichert G, Diwan MV, Dolinski MJ, Erickson A, Febbraro M, Foust BT, Gaison JK, Galindo-Uribarri A, Gilbert CE, Gilje KE, Glenn A, Goddard BW, Hackett BT, Han K, Hans S, Hansell AB, Heeger KM, Heffron B, Insler J, Jaffe DE, Ji X, Jones DC, Koehler K, Kyzylova O, Lane CE, Langford TJ, LaRosa J, Littlejohn BR, Lopez F, Lu X, Martinez Caicedo DA, Matta JT, McKeown RD, Mendenhall MP, Miller HJ, Minock JM, Mueller PE, Mumm HP, Napolitano J, Neilson R, Nikkel JA, Norcini D, Nour S, Pushin DA, Qian X, Romero-Romero E, Rosero R, Sarenac D, Seilhan BS, Sharma R, Surukuchi PT, Trinh C, Tyra MA, Varner RL, Viren B, Wagner JM, Wang W, White B, White C, Wilhelmi J, Wise T, Yao H, Yeh M, Yen YR, Zhang A, Zhang C, Zhang X, Zhao M. First Search for Short-Baseline Neutrino Oscillations at HFIR with PROSPECT. Phys Rev Lett 2018; 121:251802. [PMID: 30608854 DOI: 10.1103/physrevlett.121.251802] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 06/15/2018] [Indexed: 06/09/2023]
Abstract
This Letter reports the first scientific results from the observation of antineutrinos emitted by fission products of ^{235}U at the High Flux Isotope Reactor. PROSPECT, the Precision Reactor Oscillation and Spectrum Experiment, consists of a segmented 4 ton ^{6}Li-doped liquid scintillator detector covering a baseline range of 7-9 m from the reactor and operating under less than 1 m water equivalent overburden. Data collected during 33 live days of reactor operation at a nominal power of 85 MW yield a detection of 25 461±283 (stat) inverse beta decays. Observation of reactor antineutrinos can be achieved in PROSPECT at 5σ statistical significance within 2 h of on-surface reactor-on data taking. A reactor model independent analysis of the inverse beta decay prompt energy spectrum as a function of baseline constrains significant portions of the previously allowed sterile neutrino oscillation parameter space at 95% confidence level and disfavors the best fit of the reactor antineutrino anomaly at 2.2σ confidence level.
Collapse
Affiliation(s)
- J Ashenfelter
- Wright Laboratory, Department of Physics, Yale University, New Haven, Connecticut 06520, USA
| | - A B Balantekin
- Department of Physics, University of Wisconsin, Madison, Madison, Wisconsin 53706, USA
| | - C Baldenegro
- Physics Division, Oak Ridge National Laboratory, Oak Ridge, Tennessee 37830, USA
| | - H R Band
- Wright Laboratory, Department of Physics, Yale University, New Haven, Connecticut 06520, USA
| | - C D Bass
- Department of Physics, Le Moyne College, Syracuse, New York 13214, USA
| | - D E Bergeron
- National Institute of Standards and Technology, Gaithersburg, Maryland 20899, USA
| | - D Berish
- Department of Physics, Temple University, Philadelphia, Pennsylvania 19122, USA
| | - L J Bignell
- Brookhaven National Laboratory, Upton, New York 11973, USA
| | - N S Bowden
- Nuclear and Chemical Sciences Division, Lawrence Livermore National Laboratory, Livermore, California 94550, USA
| | - J Bricco
- Physical Sciences Laboratory, University of Wisconsin, Madison, Madison, Wisconsin 53706, USA
| | - J P Brodsky
- Nuclear and Chemical Sciences Division, Lawrence Livermore National Laboratory, Livermore, California 94550, USA
| | - C D Bryan
- High Flux Isotope Reactor, Oak Ridge National Laboratory, Oak Ridge, Tennessee 37830, USA
| | - A Bykadorova Telles
- Wright Laboratory, Department of Physics, Yale University, New Haven, Connecticut 06520, USA
| | - J J Cherwinka
- Physical Sciences Laboratory, University of Wisconsin, Madison, Madison, Wisconsin 53706, USA
| | - T Classen
- Nuclear and Chemical Sciences Division, Lawrence Livermore National Laboratory, Livermore, California 94550, USA
| | - K Commeford
- Department of Physics, Drexel University, Philadelphia, Pennsylvania 19104, USA
| | - A J Conant
- George W. Woodruff School of Mechanical Engineering, Georgia Institute of Technology, Atlanta, Georgia 30332, USA
| | - A A Cox
- Institute for Quantum Computing and Department of Physics and Astronomy, University of Waterloo, Waterloo, Ontario N2L 3G1, Canada
| | - D Davee
- Department of Physics, College of William and Mary, Williamsburg, Virginia 23185, USA
| | - D Dean
- Physics Division, Oak Ridge National Laboratory, Oak Ridge, Tennessee 37830, USA
| | - G Deichert
- High Flux Isotope Reactor, Oak Ridge National Laboratory, Oak Ridge, Tennessee 37830, USA
| | - M V Diwan
- Brookhaven National Laboratory, Upton, New York 11973, USA
| | - M J Dolinski
- Department of Physics, Drexel University, Philadelphia, Pennsylvania 19104, USA
| | - A Erickson
- George W. Woodruff School of Mechanical Engineering, Georgia Institute of Technology, Atlanta, Georgia 30332, USA
| | - M Febbraro
- Physics Division, Oak Ridge National Laboratory, Oak Ridge, Tennessee 37830, USA
| | - B T Foust
- Wright Laboratory, Department of Physics, Yale University, New Haven, Connecticut 06520, USA
| | - J K Gaison
- Wright Laboratory, Department of Physics, Yale University, New Haven, Connecticut 06520, USA
| | - A Galindo-Uribarri
- Physics Division, Oak Ridge National Laboratory, Oak Ridge, Tennessee 37830, USA
- Department of Physics and Astronomy, University of Tennessee, Knoxville, Tennessee 37996, USA
| | - C E Gilbert
- Physics Division, Oak Ridge National Laboratory, Oak Ridge, Tennessee 37830, USA
- Department of Physics and Astronomy, University of Tennessee, Knoxville, Tennessee 37996, USA
| | - K E Gilje
- Department of Physics, Illinois Institute of Technology, Chicago, Illinois 60616, USA
| | - A Glenn
- Nuclear and Chemical Sciences Division, Lawrence Livermore National Laboratory, Livermore, California 94550, USA
| | - B W Goddard
- Department of Physics, Drexel University, Philadelphia, Pennsylvania 19104, USA
| | - B T Hackett
- Physics Division, Oak Ridge National Laboratory, Oak Ridge, Tennessee 37830, USA
- Department of Physics and Astronomy, University of Tennessee, Knoxville, Tennessee 37996, USA
| | - K Han
- Wright Laboratory, Department of Physics, Yale University, New Haven, Connecticut 06520, USA
| | - S Hans
- Brookhaven National Laboratory, Upton, New York 11973, USA
| | - A B Hansell
- Department of Physics, Temple University, Philadelphia, Pennsylvania 19122, USA
| | - K M Heeger
- Wright Laboratory, Department of Physics, Yale University, New Haven, Connecticut 06520, USA
| | - B Heffron
- Physics Division, Oak Ridge National Laboratory, Oak Ridge, Tennessee 37830, USA
- Department of Physics and Astronomy, University of Tennessee, Knoxville, Tennessee 37996, USA
| | - J Insler
- Department of Physics, Drexel University, Philadelphia, Pennsylvania 19104, USA
| | - D E Jaffe
- Brookhaven National Laboratory, Upton, New York 11973, USA
| | - X Ji
- Brookhaven National Laboratory, Upton, New York 11973, USA
| | - D C Jones
- Department of Physics, Temple University, Philadelphia, Pennsylvania 19122, USA
| | - K Koehler
- Physical Sciences Laboratory, University of Wisconsin, Madison, Madison, Wisconsin 53706, USA
| | - O Kyzylova
- Department of Physics, Drexel University, Philadelphia, Pennsylvania 19104, USA
| | - C E Lane
- Department of Physics, Drexel University, Philadelphia, Pennsylvania 19104, USA
| | - T J Langford
- Wright Laboratory, Department of Physics, Yale University, New Haven, Connecticut 06520, USA
| | - J LaRosa
- National Institute of Standards and Technology, Gaithersburg, Maryland 20899, USA
| | - B R Littlejohn
- Department of Physics, Illinois Institute of Technology, Chicago, Illinois 60616, USA
| | - F Lopez
- Wright Laboratory, Department of Physics, Yale University, New Haven, Connecticut 06520, USA
| | - X Lu
- Physics Division, Oak Ridge National Laboratory, Oak Ridge, Tennessee 37830, USA
- Department of Physics and Astronomy, University of Tennessee, Knoxville, Tennessee 37996, USA
| | - D A Martinez Caicedo
- Department of Physics, Illinois Institute of Technology, Chicago, Illinois 60616, USA
| | - J T Matta
- Physics Division, Oak Ridge National Laboratory, Oak Ridge, Tennessee 37830, USA
| | - R D McKeown
- Department of Physics, College of William and Mary, Williamsburg, Virginia 23185, USA
| | - M P Mendenhall
- Nuclear and Chemical Sciences Division, Lawrence Livermore National Laboratory, Livermore, California 94550, USA
| | - H J Miller
- National Institute of Standards and Technology, Gaithersburg, Maryland 20899, USA
| | - J M Minock
- Department of Physics, Drexel University, Philadelphia, Pennsylvania 19104, USA
| | - P E Mueller
- Physics Division, Oak Ridge National Laboratory, Oak Ridge, Tennessee 37830, USA
| | - H P Mumm
- National Institute of Standards and Technology, Gaithersburg, Maryland 20899, USA
| | - J Napolitano
- Department of Physics, Temple University, Philadelphia, Pennsylvania 19122, USA
| | - R Neilson
- Department of Physics, Drexel University, Philadelphia, Pennsylvania 19104, USA
| | - J A Nikkel
- Wright Laboratory, Department of Physics, Yale University, New Haven, Connecticut 06520, USA
| | - D Norcini
- Wright Laboratory, Department of Physics, Yale University, New Haven, Connecticut 06520, USA
| | - S Nour
- National Institute of Standards and Technology, Gaithersburg, Maryland 20899, USA
| | - D A Pushin
- Institute for Quantum Computing and Department of Physics and Astronomy, University of Waterloo, Waterloo, Ontario N2L 3G1, Canada
| | - X Qian
- Brookhaven National Laboratory, Upton, New York 11973, USA
| | - E Romero-Romero
- Physics Division, Oak Ridge National Laboratory, Oak Ridge, Tennessee 37830, USA
- Department of Physics and Astronomy, University of Tennessee, Knoxville, Tennessee 37996, USA
| | - R Rosero
- Brookhaven National Laboratory, Upton, New York 11973, USA
| | - D Sarenac
- Institute for Quantum Computing and Department of Physics and Astronomy, University of Waterloo, Waterloo, Ontario N2L 3G1, Canada
| | - B S Seilhan
- Nuclear and Chemical Sciences Division, Lawrence Livermore National Laboratory, Livermore, California 94550, USA
| | - R Sharma
- Brookhaven National Laboratory, Upton, New York 11973, USA
| | - P T Surukuchi
- Department of Physics, Illinois Institute of Technology, Chicago, Illinois 60616, USA
| | - C Trinh
- Department of Physics, Drexel University, Philadelphia, Pennsylvania 19104, USA
| | - M A Tyra
- National Institute of Standards and Technology, Gaithersburg, Maryland 20899, USA
| | - R L Varner
- Physics Division, Oak Ridge National Laboratory, Oak Ridge, Tennessee 37830, USA
| | - B Viren
- Brookhaven National Laboratory, Upton, New York 11973, USA
| | - J M Wagner
- Department of Physics, Drexel University, Philadelphia, Pennsylvania 19104, USA
| | - W Wang
- Department of Physics, College of William and Mary, Williamsburg, Virginia 23185, USA
| | - B White
- Physics Division, Oak Ridge National Laboratory, Oak Ridge, Tennessee 37830, USA
| | - C White
- Department of Physics, Illinois Institute of Technology, Chicago, Illinois 60616, USA
| | - J Wilhelmi
- Department of Physics, Temple University, Philadelphia, Pennsylvania 19122, USA
| | - T Wise
- Wright Laboratory, Department of Physics, Yale University, New Haven, Connecticut 06520, USA
| | - H Yao
- Department of Physics, College of William and Mary, Williamsburg, Virginia 23185, USA
| | - M Yeh
- Brookhaven National Laboratory, Upton, New York 11973, USA
| | - Y-R Yen
- Department of Physics, Drexel University, Philadelphia, Pennsylvania 19104, USA
| | - A Zhang
- Brookhaven National Laboratory, Upton, New York 11973, USA
| | - C Zhang
- Brookhaven National Laboratory, Upton, New York 11973, USA
| | - X Zhang
- Department of Physics, Illinois Institute of Technology, Chicago, Illinois 60616, USA
| | - M Zhao
- Brookhaven National Laboratory, Upton, New York 11973, USA
| |
Collapse
|
77
|
N'Djessan JJ, Yao H, Ekou A, Ehouman E, Adoubi A, Kouamé I, Konin C. [Pulmonary embolism and complete atrioventricular block]. J Med Vasc 2018; 43:375-378. [PMID: 30522711 DOI: 10.1016/j.jdmv.2018.08.002] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 03/22/2018] [Accepted: 08/11/2018] [Indexed: 11/16/2022]
Abstract
Complete atrioventricular block is a rare complication of pulmonary embolism. We describe the case of a black African patient, aged 42 years, who presented to the emergency department of Abidjan Heart Institute for sudden onset dyspnea and hemoptysis. ECG revealed a third degree atrioventricular block. Computed tomographic angiography showed proximal pulmonary embolism of the right main pulmonary artery. To our knowledge, this is the first case of complete atrioventricular block in pulmonary embolism in Sub-Saharan Africa. In case of pulmonary embolism, clinical and electrocardiographic monitoring is necessary in order to identify this uncommon and potentially serious outcome.
Collapse
Affiliation(s)
- J J N'Djessan
- Institut de cardiologie d'Abidjan, 01 BP V, 206 Abidjan, Côte d'Ivoire.
| | - H Yao
- Institut de cardiologie d'Abidjan, 01 BP V, 206 Abidjan, Côte d'Ivoire
| | - A Ekou
- Institut de cardiologie d'Abidjan, 01 BP V, 206 Abidjan, Côte d'Ivoire
| | - E Ehouman
- Institut de cardiologie d'Abidjan, 01 BP V, 206 Abidjan, Côte d'Ivoire
| | - A Adoubi
- Institut de cardiologie d'Abidjan, 01 BP V, 206 Abidjan, Côte d'Ivoire
| | - I Kouamé
- Institut de cardiologie d'Abidjan, 01 BP V, 206 Abidjan, Côte d'Ivoire
| | - C Konin
- Institut de cardiologie d'Abidjan, 01 BP V, 206 Abidjan, Côte d'Ivoire
| |
Collapse
|
78
|
Yao H, LIU Y, Jin J, Kong F. NTCP Model for Radiation Pneumonitis after Stereotactic Body Radiation Therapy in Non-Small Cell Lung Cancer Patients. Int J Radiat Oncol Biol Phys 2018. [DOI: 10.1016/j.ijrobp.2018.07.1923] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
|
79
|
Kong F, Zhang H, LIU Y, Yao H, Cerra-Franco A, Shiue K, Vile D, Wang W, Langer M, Watson G, Bartlett G, Diab K, Birdas T, Timmerman R, Lautenschlaeger T, Jin J. Radiation to the Immune System May be an Important Risk Factor for Long-term Survival after SBRT in Early Stage Non-small Cell Lung Cancer: A Role of RT Plan Optimization. Int J Radiat Oncol Biol Phys 2018. [DOI: 10.1016/j.ijrobp.2018.07.1857] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
|
80
|
Yan P, Zhang L, Li FY, Yang Y, Wang YN, Huang AM, Dai YL, Yao H. [Evaluation of ergonomic load of clinical nursing procedures]. Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi 2018; 35:581-584. [PMID: 29081125 DOI: 10.3760/cma.j.issn.1001-9391.2017.08.006] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Abstract
Objective: To evaluate the ergonomic load of clinical nursing procedures and to provide evidence for the prevention and management of work-related musculoskeletal disorders (WMSDs) in nurses. Methods: Based on the nursing unit characteristics and the common departments involving patient-turning procedures, 552 nurses were selected from 6 clinical departments from July to September, 2016. The ergonomic load of four types of patient-turning procedures, i.e., turning the patient's body, changing the bed linen of in-bed patients, moving patients, and chest physiotherapy, was evaluated by the on-site inspectors and self-evaluated by the operators using the Quick Exposure Check. The exposure value, exposure level, and exposure rate of WMSDs were assessed based on the procedure-related physical loads on the back, shoulders/arms, wrists/hands and neck, as well as the loads from work rhythm and work pressure. Results: All surveyed subjects were females who were aged mostly between 26-30 years (49.46%) , with a mean age of 29.66±5.28 years. These nurses were mainly from the Department of Infection (28.99%) and Spine Surgery (21.56%) . There were significant differences in the back, shoulders/arms, neck, work rhythm, and work pressure scores between different nursing procedures (F=16.613, 5.884, 3.431, 3.222, and 5.085, respectively; P<0.05) . Patient-turning nursing procedures resulted in high to intermediate physical load in nurses. Procedures with high to low level of WMSDs exposure were patient turning (72.69%) , bed linen changing (67.15%) , patient transfer (65.82%) , and chest physiotherapy (58.34%) . In particular, patient turning was considered as very high-risk procedure, whereas others were considered as high-risk procedures. Conclusion: Patient-turning nursing procedures result in high ergonomic load in the operators. Therefore, more focus should be placed on the ergonomics of the caretakers and nurses.
Collapse
Affiliation(s)
- P Yan
- The First Affiliated Hospital of Xinjiang Medical University, Urumqi 830054, China
| | | | | | | | | | | | | | | |
Collapse
|
81
|
Wang Y, Bu T, Yan P, Yao H. Comparison of Incidence and Risk of Depression in Recipients of Renal Transplantation and Patients Undergoing Hemodialysis in China. Transplant Proc 2018; 50:3449-3451. [PMID: 30577220 DOI: 10.1016/j.transproceed.2018.07.029] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/17/2018] [Accepted: 07/18/2018] [Indexed: 10/28/2022]
Abstract
AIM To investigate depressive symptoms in recipients of renal transplantation (RTx) compared with patients undergoing hemodialysis (HD) in China. METHODS Forty-two Chinese recipients of transplant and 42 Chinese patients on hemodialysis were randomly selected from 2011 to 2012. These 2 groups were assessed with the validated Chinese versions of Hospital Anxiety Depression Scales and Structured Clinical Interview for the Diagnostic and Statistical Manual, fourth edition-after matching by sex, age, marital status, educational background, and somatic comorbidities-for investigation of the relationships of depressive symptoms with sex and family income. RESULTS Irritability was common among both groups, but no significant difference was found. Patients undergoing RTx were less likely than patients of HD to report depressive mood (26.1% vs 38.1%; P < .05), diminished interest or pleasure (14.3% vs 31.0%; P < .05), and suicidal ideation including recurrent thoughts of death (33.3% vs 54.8%; P < .05). CONCLUSIONS Among Chinese patients with end-stage renal disease, improved renal health after RTx reduced the incidence and risk of depression compared with HD. The effective profiling of patients with end-stage renal disease, treated with both RTx and HD, should be more extensive, including examination of all facets of their mental and emotional well-being, to accurately screen for depression.
Collapse
Affiliation(s)
- Y Wang
- School of Public Health, Xinjiang Medical University, Xinjiang, China; The Key Laboratory of Xinjiang Metabolic Disease, Clinical Medical Research Institute, the First Affiliated Hospital of Xinjiang Medical University, Urumqi, China
| | - T Bu
- Center of Information and Statistics, the First Affiliated Hospital of Xinjiang Medical University, Xinjiang, China
| | - P Yan
- School of Public Health, Xinjiang Medical University, Xinjiang, China; The Key Laboratory of Xinjiang Metabolic Disease, Clinical Medical Research Institute, the First Affiliated Hospital of Xinjiang Medical University, Urumqi, China
| | - H Yao
- School of Public Health, Xinjiang Medical University, Xinjiang, China; The Key Laboratory of Xinjiang Metabolic Disease, Clinical Medical Research Institute, the First Affiliated Hospital of Xinjiang Medical University, Urumqi, China.
| |
Collapse
|
82
|
Abstract
Craniofacial secondary cartilages of the mandibular condyle and temporomandibular joint (TMJ) eminence grow in response to the local mechanical environment. The intervening TMJ disc distributes normal loads over the cartilage surfaces and provides lubrication. A better understanding of the mechanical environment and its effects on growth, development, and degeneration of the TMJ may improve treatments aimed at modifying jaw growth and preventing or reversing degenerative joint disease (DJD). This review highlights data recorded in human subjects and from computer modeling that elucidate the role of mechanics in TMJ ontogeny. Presented data provide an approximation of the age-related changes in jaw-loading behaviors and TMJ contact mechanics. The cells of the mandibular condyle, eminence, and disc respond to the mechanical environment associated with behaviors and ultimately determine the TMJ components' mature morphologies and susceptibility to precocious development of DJD compared to postcranial joints. The TMJ disc may be especially prone to degenerative change due to its avascularity and steep oxygen and glucose gradients consequent to high cell density and rate of nutrient consumption, as well as low solute diffusivities. The combined effects of strain-related hypoxia and limited glucose concentrations dramatically affect synthesis of the extracellular matrix (ECM), which limit repair capabilities. Magnitude and frequency of jaw loading influence this localized in situ environment, including stem and fibrocartilage cell chemistry, as well as the rate of ECM mechanical fatigue. Key in vivo measurements to characterize the mechanical environment include the concentration of work input to articulating tissues, known as energy density, and the percentage of time that muscles are used to load the jaws out of a total recording time, known as duty factor. Combining these measurements into a mechanobehavioral score and linking these to results of computer models of strain-regulated biochemical events may elucidate the mechanisms responsible for growth, maintenance, and deterioration of TMJ tissues.
Collapse
Affiliation(s)
- J C Nickel
- 1 Department of Orthodontics, School of Dentistry, Oregon Health & Science University, Portland, OR, USA.,2 Department of Oral Diagnostic Sciences, School of Dental Medicine, University at Buffalo, Buffalo, NY, USA
| | - L R Iwasaki
- 1 Department of Orthodontics, School of Dentistry, Oregon Health & Science University, Portland, OR, USA.,2 Department of Oral Diagnostic Sciences, School of Dental Medicine, University at Buffalo, Buffalo, NY, USA
| | - Y M Gonzalez
- 2 Department of Oral Diagnostic Sciences, School of Dental Medicine, University at Buffalo, Buffalo, NY, USA
| | - L M Gallo
- 3 Department of Masticatory Disorders, University of Zurich School of Dental Medicine, Zurich, Switzerland
| | - H Yao
- 4 Department of Bioengineering, Clemson University, Clemson, SC, USA.,5 Department of Oral Health Sciences, College of Dental Medicine, Medical University of South Carolina, Charleston, SC, USA
| |
Collapse
|
83
|
Wu Y, Cisewski SE, Wei F, She X, Gonzales TS, Iwasaki LR, Nickel JC, Yao H. Fluid pressurization and tractional forces during TMJ disc loading: A biphasic finite element analysis. Orthod Craniofac Res 2018. [PMID: 28643926 DOI: 10.1111/ocr.12147] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Abstract
OBJECTIVES To investigate the ploughing mechanism associated with tractional force formation on the temporomandibular joint (TMJ) disc surface. SETTING AND SAMPLE POPULATION Ten left TMJ discs were harvested from 6- to 8-month-old male Yorkshire pigs. MATERIALS AND METHODS Confined compression tests characterized mechanical TMJ disc properties, which were incorporated into a biphasic finite element model (FEM). The FEM was established to investigate load carriage within the extracellular matrix (ECM) and the ploughing mechanism during tractional force formation by simulating previous in vitro plough experiments. RESULTS Biphasic mechanical properties were determined in five TMJ disc regions (average±standard deviation for aggregate modulus: 0.077±0.040 MPa; hydraulic permeability: 0.88±0.37×10-3 mm4 /Ns). FE simulation results demonstrated that interstitial fluid pressurization is a dominant loading support mechanism in the TMJ disc. Increased contact load and duration led to increased solid ECM strain and stress within, and increased ploughing force on the surface of the disc. CONCLUSION Sustained mechanical loading may play a role in load carriage within the ECM and ploughing force formation during stress-field translation at the condyle-disc interface. This study further elucidated the mechanism of ploughing on tractional force formation and provided a baseline for future analysis of TMJ mechanics, cartilage fatigue and early TMJ degeneration.
Collapse
Affiliation(s)
- Y Wu
- Department of Bioengineering, Clemson University, Clemson, SC, USA.,Department of Orthopaedics, Medical University of South Carolina (MUSC), Charleston, SC, USA
| | - S E Cisewski
- Department of Bioengineering, Clemson University, Clemson, SC, USA
| | - F Wei
- Department of Bioengineering, Clemson University, Clemson, SC, USA
| | - X She
- Department of Bioengineering, Clemson University, Clemson, SC, USA
| | - T S Gonzales
- Department of Oral Health Sciences, MUSC, Charleston, SC, USA
| | - L R Iwasaki
- Department of Orthodontics and Dentofacial Orthopaedics, University of Missouri-Kansas City, Kansas City, MO, USA
| | - J C Nickel
- Department of Orthodontics and Dentofacial Orthopaedics, University of Missouri-Kansas City, Kansas City, MO, USA
| | - H Yao
- Department of Bioengineering, Clemson University, Clemson, SC, USA.,Department of Orthopaedics, Medical University of South Carolina (MUSC), Charleston, SC, USA.,Department of Oral Health Sciences, MUSC, Charleston, SC, USA
| |
Collapse
|
84
|
Xie M, Zheng D, Yao H, Wang Z. Vesicovaginal fistula repair through combined transurethral and transvaginal approaches: A case series study. J Gynecol Obstet Hum Reprod 2018; 47:487-490. [PMID: 29783034 DOI: 10.1016/j.jogoh.2018.05.004] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/25/2018] [Revised: 05/14/2018] [Accepted: 05/17/2018] [Indexed: 01/09/2023]
Abstract
We report a case series study on five patients who underwent combined transurethral and transvaginal approaches to repair their vesicovaginal fistulas. All of them had failed the previous surgical treatments for their fistulas. Combined transurethral and transvaginal approaches successfully repaired their vesicovaginal fistulas, with minimal intraoperative bleeding and rapid postoperative recoveries. All the clinical symptoms had resolved. Bladder saline infusion tests and cystogram examinations confirmed the successful closure of their fistulas. Follow-up examinations up to one and a half years showed no return of clinical symptoms. Combined transurethral and transvaginal approaches could be successfully applied to patients who failed previous surgical treatments for the vesicovaginal fistula, when the fistula was smaller than 3cm and was located more than 0.5cm from the ureteral orifice.
Collapse
Affiliation(s)
- M Xie
- Shanghai Ninth People's Hospital, Shanghai Jiao Tong University, School of Medicine, Shanghai 200025, China
| | - D Zheng
- Shanghai Ninth People's Hospital, Shanghai Jiao Tong University, School of Medicine, Shanghai 200025, China
| | - H Yao
- Shanghai Ninth People's Hospital, Shanghai Jiao Tong University, School of Medicine, Shanghai 200025, China.
| | - Z Wang
- Shanghai Ninth People's Hospital, Shanghai Jiao Tong University, School of Medicine, Shanghai 200025, China.
| |
Collapse
|
85
|
Yao H, Zhang Y, Yi X, Zhang X, Fan D, Chow WS, Zhang W. Diaheliotropic leaf movement enhances leaf photosynthetic capacity and photosynthetic light and nitrogen use efficiency via optimising nitrogen partitioning among photosynthetic components in cotton (Gossypium hirsutum L.). Plant Biol (Stuttg) 2018; 20:213-222. [PMID: 29222927 DOI: 10.1111/plb.12678] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 09/28/2017] [Accepted: 12/01/2017] [Indexed: 06/07/2023]
Abstract
Phototropic leaf movement of plants is an effective mechanism for adapting to light conditions. Light is the major driver of plant photosynthesis. Leaf N is also an important limiting factor on leaf photosynthetic potential. Cotton (Gossypium hirsutum L.) exhibits diaheliotropic leaf movement. Here, we compared the long-term photosynthetic acclimation of fixed leaves (restrained) and free leaves (allowed free movement) in cotton. The fixed leaves and free leaves were used for determination of PAR, leaf chlorophyll concentration, leaf N content and leaf gas exchange. The measurements were conducted under clear sky conditions at 0, 7, 15 and 30 days after treatment (DAT). The results showed that leaf N allocation and partitioning among different components of the photosynthetic apparatus were significantly affected by diaheliotropic leaf movement. Diaheliotropic leaf movement significantly increased light interception per unit leaf area, which in turn affected leaf mass per area (LMA), leaf N content (NA ) and leaf N allocation to photosynthesis (NP ). In addition, cotton leaves optimised leaf N allocation to the photosynthetic apparatus by adjusting leaf mass per area and NA in response to optimal light interception. In the presence of diaheliotropic leaf movement, cotton leaves optimised their structural tissue and photosynthetic characteristics, such as LMA, NA and leaf N allocation to photosynthesis, so that leaf photosynthetic capacity was maximised to improve the photosynthetic use efficiency of light and N under high light conditions.
Collapse
Affiliation(s)
- H Yao
- The Key Laboratory of Oasis Eco-agriculture, Xinjiang Production and Construction Corps, Shihezi University, Shihezi, Xinjiang, China
- Division of Plant Sciences, Research School of Biology, The Australian National University, Acton, Australia
| | - Y Zhang
- The Key Laboratory of Oasis Eco-agriculture, Xinjiang Production and Construction Corps, Shihezi University, Shihezi, Xinjiang, China
| | - X Yi
- The Key Laboratory of Oasis Eco-agriculture, Xinjiang Production and Construction Corps, Shihezi University, Shihezi, Xinjiang, China
| | - X Zhang
- The Key Laboratory of Oasis Eco-agriculture, Xinjiang Production and Construction Corps, Shihezi University, Shihezi, Xinjiang, China
| | - D Fan
- Division of Plant Sciences, Research School of Biology, The Australian National University, Acton, Australia
| | - W S Chow
- Division of Plant Sciences, Research School of Biology, The Australian National University, Acton, Australia
| | - W Zhang
- The Key Laboratory of Oasis Eco-agriculture, Xinjiang Production and Construction Corps, Shihezi University, Shihezi, Xinjiang, China
| |
Collapse
|
86
|
Korpal M, Puyang X, Furman C, Zheng GZ, Banka D, Wu J, Zhang Z, Thomas M, Mackenzie C, Yao H, Rimkunas V, Kumar P, Caleb B, Karr C, Subramanian V, Irwin S, Larsen N, Vaillancourt F, Nguyen TV, Davis A, Chan B, Hao MH, O'Shea M, Prajapati S, Agoulnik S, Kuznetsov G, Kumar N, Yu Y, Lai G, Hart A, Eckley S, Fekkes P, Bowser T, Joshi JJ, Selvaraj A, Wardell S, Norris J, Smith S, Reynolds D, Mitchell L, Wang J, Yu L, Kim A, Rioux N, Sahmoud T, Warmuth M, Smith PG, Zhu P. Abstract P1-10-08: Development of a first-in-class oral selective ERα covalent antagonist (SERCA) for the treatment of ERαWT and ERαMUT breast cancer. Cancer Res 2018. [DOI: 10.1158/1538-7445.sabcs17-p1-10-08] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Abstract
Mutations in estrogen receptor alpha (ERα) are detected in up to 30% of breast cancer patients who have relapsed during endocrine therapy. ERα mutations functionally confer resistance to existing classes of endocrine therapies, likely through gaining constitutive activity. The fact that current ER-directed therapies are only partially effective in the ERα mutant setting, and that a significant proportion of resistant breast cancer metastases continue to remain dependent on ERα signaling for growth/survival, highlights the critical need to develop the next generation of ERα antagonists that can overcome aberrant ERα activity. Using structure-based drug design approaches we have identified a novel class of ERα antagonist referred to as Selective ERα Covalent Antagonist (SERCA) that inactivate both wild-type and mutant ERα by targeting a unique cysteine residue that is not conserved among other steroid hormone receptors. Biophysical, biochemical and cellular analyses confirm the covalent mechanism of action, specific binding to ER and selective inhibition of ERα-dependent transcription of SERCAs. H3B-6545 is a highly selective SERCA that potently antagonizes wild-type and mutant ERα in biochemical and cell based assays demonstrating increased potency over standard of care and other experimental agents. In vivo, H3B-6545 shows superior efficacy to fulvestrant in the MCF-7 xenograft model with once daily oral dosing, achieving maximal antitumor activity at doses >10x below the maximum tolerated dose in mice. In addition, H3B-6545 shows superior antitumor activity to both tamoxifen and fulvestrant in patient derived xenograft models of breast cancer carrying estrogen receptor mutations. In summary, H3B-6545 is a first-in-class, orally available and selective ER covalent antagonist with a compelling pre-clinical profile that is being developed for the treatment of ERα positive breast cancer.
Citation Format: Korpal M, Puyang X, Furman C, Zheng GZ, Banka D, Wu J, Zhang Z, Thomas M, Mackenzie C, Yao H, Rimkunas V, Kumar P, Caleb B, Karr C, Subramanian V, Irwin S, Larsen N, Vaillancourt F, Nguyen T-V, Davis A, Chan B, Hao MH, O'Shea M, Prajapati S, Agoulnik S, Kuznetsov G, Kumar N, Yu Y, Lai G, Hart A, Eckley S, Fekkes P, Bowser T, Joshi JJ, Selvaraj A, Wardell S, Norris J, Smith S, Reynolds D, Mitchell L, Wang J, Yu L, Kim A, Rioux N, Sahmoud T, Warmuth M, Smith PG, Zhu P. Development of a first-in-class oral selective ERα covalent antagonist (SERCA) for the treatment of ERαWT and ERαMUT breast cancer [abstract]. In: Proceedings of the 2017 San Antonio Breast Cancer Symposium; 2017 Dec 5-9; San Antonio, TX. Philadelphia (PA): AACR; Cancer Res 2018;78(4 Suppl):Abstract nr P1-10-08.
Collapse
Affiliation(s)
- M Korpal
- H3 Biomedicine, Inc., 300 Technology Square, Cambridge, MA; Eisai Inc., 4 Corporate Drive, Andover, MA; Duke University, Research Drive, LSRC Bldg, C251, Durham, NC
| | - X Puyang
- H3 Biomedicine, Inc., 300 Technology Square, Cambridge, MA; Eisai Inc., 4 Corporate Drive, Andover, MA; Duke University, Research Drive, LSRC Bldg, C251, Durham, NC
| | - C Furman
- H3 Biomedicine, Inc., 300 Technology Square, Cambridge, MA; Eisai Inc., 4 Corporate Drive, Andover, MA; Duke University, Research Drive, LSRC Bldg, C251, Durham, NC
| | - GZ Zheng
- H3 Biomedicine, Inc., 300 Technology Square, Cambridge, MA; Eisai Inc., 4 Corporate Drive, Andover, MA; Duke University, Research Drive, LSRC Bldg, C251, Durham, NC
| | - D Banka
- H3 Biomedicine, Inc., 300 Technology Square, Cambridge, MA; Eisai Inc., 4 Corporate Drive, Andover, MA; Duke University, Research Drive, LSRC Bldg, C251, Durham, NC
| | - J Wu
- H3 Biomedicine, Inc., 300 Technology Square, Cambridge, MA; Eisai Inc., 4 Corporate Drive, Andover, MA; Duke University, Research Drive, LSRC Bldg, C251, Durham, NC
| | - Z Zhang
- H3 Biomedicine, Inc., 300 Technology Square, Cambridge, MA; Eisai Inc., 4 Corporate Drive, Andover, MA; Duke University, Research Drive, LSRC Bldg, C251, Durham, NC
| | - M Thomas
- H3 Biomedicine, Inc., 300 Technology Square, Cambridge, MA; Eisai Inc., 4 Corporate Drive, Andover, MA; Duke University, Research Drive, LSRC Bldg, C251, Durham, NC
| | - C Mackenzie
- H3 Biomedicine, Inc., 300 Technology Square, Cambridge, MA; Eisai Inc., 4 Corporate Drive, Andover, MA; Duke University, Research Drive, LSRC Bldg, C251, Durham, NC
| | - H Yao
- H3 Biomedicine, Inc., 300 Technology Square, Cambridge, MA; Eisai Inc., 4 Corporate Drive, Andover, MA; Duke University, Research Drive, LSRC Bldg, C251, Durham, NC
| | - V Rimkunas
- H3 Biomedicine, Inc., 300 Technology Square, Cambridge, MA; Eisai Inc., 4 Corporate Drive, Andover, MA; Duke University, Research Drive, LSRC Bldg, C251, Durham, NC
| | - P Kumar
- H3 Biomedicine, Inc., 300 Technology Square, Cambridge, MA; Eisai Inc., 4 Corporate Drive, Andover, MA; Duke University, Research Drive, LSRC Bldg, C251, Durham, NC
| | - B Caleb
- H3 Biomedicine, Inc., 300 Technology Square, Cambridge, MA; Eisai Inc., 4 Corporate Drive, Andover, MA; Duke University, Research Drive, LSRC Bldg, C251, Durham, NC
| | - C Karr
- H3 Biomedicine, Inc., 300 Technology Square, Cambridge, MA; Eisai Inc., 4 Corporate Drive, Andover, MA; Duke University, Research Drive, LSRC Bldg, C251, Durham, NC
| | - V Subramanian
- H3 Biomedicine, Inc., 300 Technology Square, Cambridge, MA; Eisai Inc., 4 Corporate Drive, Andover, MA; Duke University, Research Drive, LSRC Bldg, C251, Durham, NC
| | - S Irwin
- H3 Biomedicine, Inc., 300 Technology Square, Cambridge, MA; Eisai Inc., 4 Corporate Drive, Andover, MA; Duke University, Research Drive, LSRC Bldg, C251, Durham, NC
| | - N Larsen
- H3 Biomedicine, Inc., 300 Technology Square, Cambridge, MA; Eisai Inc., 4 Corporate Drive, Andover, MA; Duke University, Research Drive, LSRC Bldg, C251, Durham, NC
| | - F Vaillancourt
- H3 Biomedicine, Inc., 300 Technology Square, Cambridge, MA; Eisai Inc., 4 Corporate Drive, Andover, MA; Duke University, Research Drive, LSRC Bldg, C251, Durham, NC
| | - T-V Nguyen
- H3 Biomedicine, Inc., 300 Technology Square, Cambridge, MA; Eisai Inc., 4 Corporate Drive, Andover, MA; Duke University, Research Drive, LSRC Bldg, C251, Durham, NC
| | - A Davis
- H3 Biomedicine, Inc., 300 Technology Square, Cambridge, MA; Eisai Inc., 4 Corporate Drive, Andover, MA; Duke University, Research Drive, LSRC Bldg, C251, Durham, NC
| | - B Chan
- H3 Biomedicine, Inc., 300 Technology Square, Cambridge, MA; Eisai Inc., 4 Corporate Drive, Andover, MA; Duke University, Research Drive, LSRC Bldg, C251, Durham, NC
| | - MH Hao
- H3 Biomedicine, Inc., 300 Technology Square, Cambridge, MA; Eisai Inc., 4 Corporate Drive, Andover, MA; Duke University, Research Drive, LSRC Bldg, C251, Durham, NC
| | - M O'Shea
- H3 Biomedicine, Inc., 300 Technology Square, Cambridge, MA; Eisai Inc., 4 Corporate Drive, Andover, MA; Duke University, Research Drive, LSRC Bldg, C251, Durham, NC
| | - S Prajapati
- H3 Biomedicine, Inc., 300 Technology Square, Cambridge, MA; Eisai Inc., 4 Corporate Drive, Andover, MA; Duke University, Research Drive, LSRC Bldg, C251, Durham, NC
| | - S Agoulnik
- H3 Biomedicine, Inc., 300 Technology Square, Cambridge, MA; Eisai Inc., 4 Corporate Drive, Andover, MA; Duke University, Research Drive, LSRC Bldg, C251, Durham, NC
| | - G Kuznetsov
- H3 Biomedicine, Inc., 300 Technology Square, Cambridge, MA; Eisai Inc., 4 Corporate Drive, Andover, MA; Duke University, Research Drive, LSRC Bldg, C251, Durham, NC
| | - N Kumar
- H3 Biomedicine, Inc., 300 Technology Square, Cambridge, MA; Eisai Inc., 4 Corporate Drive, Andover, MA; Duke University, Research Drive, LSRC Bldg, C251, Durham, NC
| | - Y Yu
- H3 Biomedicine, Inc., 300 Technology Square, Cambridge, MA; Eisai Inc., 4 Corporate Drive, Andover, MA; Duke University, Research Drive, LSRC Bldg, C251, Durham, NC
| | - G Lai
- H3 Biomedicine, Inc., 300 Technology Square, Cambridge, MA; Eisai Inc., 4 Corporate Drive, Andover, MA; Duke University, Research Drive, LSRC Bldg, C251, Durham, NC
| | - A Hart
- H3 Biomedicine, Inc., 300 Technology Square, Cambridge, MA; Eisai Inc., 4 Corporate Drive, Andover, MA; Duke University, Research Drive, LSRC Bldg, C251, Durham, NC
| | - S Eckley
- H3 Biomedicine, Inc., 300 Technology Square, Cambridge, MA; Eisai Inc., 4 Corporate Drive, Andover, MA; Duke University, Research Drive, LSRC Bldg, C251, Durham, NC
| | - P Fekkes
- H3 Biomedicine, Inc., 300 Technology Square, Cambridge, MA; Eisai Inc., 4 Corporate Drive, Andover, MA; Duke University, Research Drive, LSRC Bldg, C251, Durham, NC
| | - T Bowser
- H3 Biomedicine, Inc., 300 Technology Square, Cambridge, MA; Eisai Inc., 4 Corporate Drive, Andover, MA; Duke University, Research Drive, LSRC Bldg, C251, Durham, NC
| | - JJ Joshi
- H3 Biomedicine, Inc., 300 Technology Square, Cambridge, MA; Eisai Inc., 4 Corporate Drive, Andover, MA; Duke University, Research Drive, LSRC Bldg, C251, Durham, NC
| | - A Selvaraj
- H3 Biomedicine, Inc., 300 Technology Square, Cambridge, MA; Eisai Inc., 4 Corporate Drive, Andover, MA; Duke University, Research Drive, LSRC Bldg, C251, Durham, NC
| | - S Wardell
- H3 Biomedicine, Inc., 300 Technology Square, Cambridge, MA; Eisai Inc., 4 Corporate Drive, Andover, MA; Duke University, Research Drive, LSRC Bldg, C251, Durham, NC
| | - J Norris
- H3 Biomedicine, Inc., 300 Technology Square, Cambridge, MA; Eisai Inc., 4 Corporate Drive, Andover, MA; Duke University, Research Drive, LSRC Bldg, C251, Durham, NC
| | - S Smith
- H3 Biomedicine, Inc., 300 Technology Square, Cambridge, MA; Eisai Inc., 4 Corporate Drive, Andover, MA; Duke University, Research Drive, LSRC Bldg, C251, Durham, NC
| | - D Reynolds
- H3 Biomedicine, Inc., 300 Technology Square, Cambridge, MA; Eisai Inc., 4 Corporate Drive, Andover, MA; Duke University, Research Drive, LSRC Bldg, C251, Durham, NC
| | - L Mitchell
- H3 Biomedicine, Inc., 300 Technology Square, Cambridge, MA; Eisai Inc., 4 Corporate Drive, Andover, MA; Duke University, Research Drive, LSRC Bldg, C251, Durham, NC
| | - J Wang
- H3 Biomedicine, Inc., 300 Technology Square, Cambridge, MA; Eisai Inc., 4 Corporate Drive, Andover, MA; Duke University, Research Drive, LSRC Bldg, C251, Durham, NC
| | - L Yu
- H3 Biomedicine, Inc., 300 Technology Square, Cambridge, MA; Eisai Inc., 4 Corporate Drive, Andover, MA; Duke University, Research Drive, LSRC Bldg, C251, Durham, NC
| | - A Kim
- H3 Biomedicine, Inc., 300 Technology Square, Cambridge, MA; Eisai Inc., 4 Corporate Drive, Andover, MA; Duke University, Research Drive, LSRC Bldg, C251, Durham, NC
| | - N Rioux
- H3 Biomedicine, Inc., 300 Technology Square, Cambridge, MA; Eisai Inc., 4 Corporate Drive, Andover, MA; Duke University, Research Drive, LSRC Bldg, C251, Durham, NC
| | - T Sahmoud
- H3 Biomedicine, Inc., 300 Technology Square, Cambridge, MA; Eisai Inc., 4 Corporate Drive, Andover, MA; Duke University, Research Drive, LSRC Bldg, C251, Durham, NC
| | - M Warmuth
- H3 Biomedicine, Inc., 300 Technology Square, Cambridge, MA; Eisai Inc., 4 Corporate Drive, Andover, MA; Duke University, Research Drive, LSRC Bldg, C251, Durham, NC
| | - PG Smith
- H3 Biomedicine, Inc., 300 Technology Square, Cambridge, MA; Eisai Inc., 4 Corporate Drive, Andover, MA; Duke University, Research Drive, LSRC Bldg, C251, Durham, NC
| | - P Zhu
- H3 Biomedicine, Inc., 300 Technology Square, Cambridge, MA; Eisai Inc., 4 Corporate Drive, Andover, MA; Duke University, Research Drive, LSRC Bldg, C251, Durham, NC
| |
Collapse
|
87
|
Yao H, Ekou A, N'Djessan JJ, Zoumenou A, Angoran I, N'Guetta R. [Spontaneous coronary artery dissection: An exceptional cause of acute coronary syndrome]. J Med Vasc 2018; 43:52-55. [PMID: 29425541 DOI: 10.1016/j.jdmv.2017.10.004] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 07/11/2017] [Accepted: 10/12/2017] [Indexed: 06/08/2023]
Abstract
Spontaneous coronary artery dissection (SCAD) is an uncommon cause of acute coronary syndrome (ACS) or sudden death, which typically affects young women. We reported two cases of black Africans patients, aged 56 and 52 years old, who presented to Abidjan Heart Institute for ACS. Coronary angiography showed spontaneous dissection of the right coronary artery in the first case, and dissection of the distal left anterior descending artery in the second. A conservative approach was preferred. Both patients received antiplatelet agents, beta-blockers, angiotensin converting enzyme inhibitors and statins, with a favorable in-hospital course. These cases highlight SCAD as a possible cause of ACS. Implementation of interventional cardiology in Sub-Saharan Africa will help identify this uncommon cause of ACS.
Collapse
Affiliation(s)
- H Yao
- Institut de cardiologie d'Abidjan, 01 BP V 206, Abidjan, Cote d'Ivoire.
| | - A Ekou
- Institut de cardiologie d'Abidjan, 01 BP V 206, Abidjan, Cote d'Ivoire
| | - J J N'Djessan
- Institut de cardiologie d'Abidjan, 01 BP V 206, Abidjan, Cote d'Ivoire
| | - A Zoumenou
- Institut de cardiologie d'Abidjan, 01 BP V 206, Abidjan, Cote d'Ivoire
| | - I Angoran
- Institut de cardiologie d'Abidjan, 01 BP V 206, Abidjan, Cote d'Ivoire
| | - R N'Guetta
- Institut de cardiologie d'Abidjan, 01 BP V 206, Abidjan, Cote d'Ivoire
| |
Collapse
|
88
|
Camsonne A, Katramatou AT, Olson M, Acha A, Allada K, Anderson BD, Arrington J, Baldwin A, Chen JP, Choi S, Chudakov E, Cisbani E, Craver B, Decowski P, Dutta C, Folts E, Frullani S, Garibaldi F, Gilman R, Gomez J, Hahn B, Hansen JO, Higinbotham DW, Holmstrom T, Huang J, Iodice M, Jiang X, Kelleher A, Khrosinkova E, Kievsky A, Kuchina E, Kumbartzki G, Lee B, LeRose JJ, Lindgren RA, Lott G, Lu H, Marcucci LE, Margaziotis DJ, Markowitz P, Marrone S, Meekins D, Meziani ZE, Michaels R, Moffit B, Norum B, Petratos GG, Puckett A, Qian X, Rondon O, Saha A, Sawatzky B, Segal J, Shabestari M, Shahinyan A, Solvignon P, Sparveris N, Subedi RR, Suleiman R, Sulkosky V, Urciuoli GM, Viviani M, Wang Y, Wojtsekhowski BB, Yan X, Yao H, Zhang WM, Zheng X, Zhu L. Publisher's Note: JLab Measurements of the ^{3}He Form Factors at Large Momentum Transfers [Phys. Rev. Lett. 119, 162501 (2017)]. Phys Rev Lett 2017; 119:209901. [PMID: 29219338 DOI: 10.1103/physrevlett.119.209901] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 11/02/2017] [Indexed: 06/07/2023]
Abstract
This corrects the article DOI: 10.1103/PhysRevLett.119.162501.
Collapse
|
89
|
Defurne M, Jiménez-Argüello AM, Ahmed Z, Albataineh H, Allada K, Aniol KA, Bellini V, Benali M, Boeglin W, Bertin P, Brossard M, Camsonne A, Canan M, Chandavar S, Chen C, Chen JP, de Jager CW, de Leo R, Desnault C, Deur A, El Fassi L, Ent R, Flay D, Friend M, Fuchey E, Frullani S, Garibaldi F, Gaskell D, Giusa A, Glamazdin O, Golge S, Gomez J, Hansen O, Higinbotham D, Holmstrom T, Horn T, Huang J, Huang M, Hyde CE, Iqbal S, Itard F, Kang H, Kelleher A, Keppel C, Koirala S, Korover I, LeRose JJ, Lindgren R, Long E, Magne M, Mammei J, Margaziotis DJ, Markowitz P, Mazouz M, Meddi F, Meekins D, Michaels R, Mihovilovic M, Camacho CM, Nadel-Turonski P, Nuruzzaman N, Paremuzyan R, Puckett A, Punjabi V, Qiang Y, Rakhman A, Rashad MNH, Riordan S, Roche J, Russo G, Sabatié F, Saenboonruang K, Saha A, Sawatzky B, Selvy L, Shahinyan A, Sirca S, Solvignon P, Sperduto ML, Subedi R, Sulkosky V, Sutera C, Tobias WA, Urciuoli GM, Wang D, Wojtsekhowski B, Yao H, Ye Z, Zhan X, Zhang J, Zhao B, Zhao Z, Zheng X, Zhu P. A glimpse of gluons through deeply virtual compton scattering on the proton. Nat Commun 2017; 8:1408. [PMID: 29123117 PMCID: PMC5680334 DOI: 10.1038/s41467-017-01819-3] [Citation(s) in RCA: 27] [Impact Index Per Article: 3.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/24/2017] [Accepted: 10/18/2017] [Indexed: 11/13/2022] Open
Abstract
The internal structure of nucleons (protons and neutrons) remains one of the greatest outstanding problems in modern nuclear physics. By scattering high-energy electrons off a proton we are able to resolve its fundamental constituents and probe their momenta and positions. Here we investigate the dynamics of quarks and gluons inside nucleons using deeply virtual Compton scattering (DVCS)-a highly virtual photon scatters off the proton, which subsequently radiates a photon. DVCS interferes with the Bethe-Heitler (BH) process, where the photon is emitted by the electron rather than the proton. We report herein the full determination of the BH-DVCS interference by exploiting the distinct energy dependences of the DVCS and BH amplitudes. In the regime where the scattering is expected to occur off a single quark, measurements show an intriguing sensitivity to gluons, the carriers of the strong interaction.
Collapse
Affiliation(s)
- M Defurne
- Irfu, CEA, Université Paris-Saclay, 91191, Gif-sur-Yvette, France.
| | - A Martí Jiménez-Argüello
- Institut de Physique Nucléaire CNRS-IN2P3, 15 rue Georges Clémenceau, 91406, Orsay, France
- Facultad de Física, Universidad de Valencia, Carrer del Dr. Moliner 50, 46100, Burjassot, Spain
| | - Z Ahmed
- Syracuse University, 900 South Crouse Ave., Syracuse, NY, 13244, USA
| | - H Albataineh
- Texas A&M University-Kingsville, Engineering Complex, 700 University Blvd, Kingsville, TX, 78363, USA
| | - K Allada
- Massachusetts Institute of Technology, 77 Massachusetts Ave, Cambridge, MA, 02139, USA
| | - K A Aniol
- California State University, 5151 State University Dr, Los Angeles, CA, 90032, USA
| | - V Bellini
- INFN/Sezione di Catania, Via S. Sofia, 62, 95125, Catania, Italy
| | - M Benali
- Clermont université, université Blaise Pascal, CNRS/IN2P3, 4 Avenue Blaise Pascal, 63178, Aubire Cedex, France
| | - W Boeglin
- Florida International University, 11200 SW 8th St, Miami, FL, 33199, USA
| | - P Bertin
- Clermont université, université Blaise Pascal, CNRS/IN2P3, 4 Avenue Blaise Pascal, 63178, Aubire Cedex, France
- Thomas Jefferson National Accelerator Facility, 12000 Jefferson Ave, Newport News, VA, 23606, USA
| | - M Brossard
- Clermont université, université Blaise Pascal, CNRS/IN2P3, 4 Avenue Blaise Pascal, 63178, Aubire Cedex, France
| | - A Camsonne
- Thomas Jefferson National Accelerator Facility, 12000 Jefferson Ave, Newport News, VA, 23606, USA
| | - M Canan
- Old Dominion University, Norfolk, 5115 Hampton Blvd, Norfolk, VA, 23529, USA
| | - S Chandavar
- Ohio University, 123 University Terrace, 1 Ohio University, Athens, OH, 45701, USA
| | - C Chen
- Hampton University, 100 E Queen St, Hampton, VA, 23668, USA
| | - J-P Chen
- Thomas Jefferson National Accelerator Facility, 12000 Jefferson Ave, Newport News, VA, 23606, USA
| | - C W de Jager
- Thomas Jefferson National Accelerator Facility, 12000 Jefferson Ave, Newport News, VA, 23606, USA
| | - R de Leo
- Università di Bari, Piazza Umberto I, 1, 70121, Bari, Italy
| | - C Desnault
- Institut de Physique Nucléaire CNRS-IN2P3, 15 rue Georges Clémenceau, 91406, Orsay, France
| | - A Deur
- Thomas Jefferson National Accelerator Facility, 12000 Jefferson Ave, Newport News, VA, 23606, USA
| | - L El Fassi
- Rutgers, The State University of New Jersey, 7 College Ave, New Brunswick, NJ, 08901, USA
| | - R Ent
- Thomas Jefferson National Accelerator Facility, 12000 Jefferson Ave, Newport News, VA, 23606, USA
| | - D Flay
- Temple University, 1801 N Broad St, Philadelphia, PA, 19122, USA
| | - M Friend
- Carnegie Mellon University, 5000 Forbes Ave, Pittsburgh, PA, 15213, USA
| | - E Fuchey
- Irfu, CEA, Université Paris-Saclay, 91191, Gif-sur-Yvette, France
- Clermont université, université Blaise Pascal, CNRS/IN2P3, 4 Avenue Blaise Pascal, 63178, Aubire Cedex, France
- University of Connecticut, 2390 Alumni Drive, Unit 3206, Storrs, CT, 06269, USA
| | - S Frullani
- INFN/Sezione Sanità, Viale Regina Elena 299, 00161, Roma, Italy
| | - F Garibaldi
- INFN/Sezione Sanità, Viale Regina Elena 299, 00161, Roma, Italy
| | - D Gaskell
- Thomas Jefferson National Accelerator Facility, 12000 Jefferson Ave, Newport News, VA, 23606, USA
| | - A Giusa
- INFN/Sezione di Catania, Via S. Sofia, 62, 95125, Catania, Italy
| | - O Glamazdin
- Kharkov Institute of Physics and Technology, Akademichna St, 1, Kharkov, Kharkiv Oblast, 61000, Ukraine
| | - S Golge
- North Carolina Central University, 1801 Fayetteville St, Durham, NC, 27707, USA
| | - J Gomez
- Thomas Jefferson National Accelerator Facility, 12000 Jefferson Ave, Newport News, VA, 23606, USA
| | - O Hansen
- Thomas Jefferson National Accelerator Facility, 12000 Jefferson Ave, Newport News, VA, 23606, USA
| | - D Higinbotham
- Thomas Jefferson National Accelerator Facility, 12000 Jefferson Ave, Newport News, VA, 23606, USA
| | - T Holmstrom
- Longwood University, 201 High St, Farmville, VA, 23909, USA
| | - T Horn
- The Catholic University of America, 620 Michigan Ave NE, Washington, DC, 20064, USA
| | - J Huang
- Massachusetts Institute of Technology, 77 Massachusetts Ave, Cambridge, MA, 02139, USA
| | - M Huang
- Duke University, Physics Bldg., Science Dr., Campus Box 90305, Durham, NC, 27708, USA
| | - C E Hyde
- Clermont université, université Blaise Pascal, CNRS/IN2P3, 4 Avenue Blaise Pascal, 63178, Aubire Cedex, France
- Old Dominion University, Norfolk, 5115 Hampton Blvd, Norfolk, VA, 23529, USA
| | - S Iqbal
- California State University, 5151 State University Dr, Los Angeles, CA, 90032, USA
| | - F Itard
- Clermont université, université Blaise Pascal, CNRS/IN2P3, 4 Avenue Blaise Pascal, 63178, Aubire Cedex, France
| | - H Kang
- Seoul National University, 1 Gwanak-ro, Gwanak-gu, Seol, South Korea
| | - A Kelleher
- College of William and Mary, Department of Physics, P.O. Box 8795, Williamsburg, VA, 23187, USA
| | - C Keppel
- Thomas Jefferson National Accelerator Facility, 12000 Jefferson Ave, Newport News, VA, 23606, USA
| | - S Koirala
- Old Dominion University, Norfolk, 5115 Hampton Blvd, Norfolk, VA, 23529, USA
| | - I Korover
- Tel Aviv University, P.O. Box 39040, Tel Aviv, 6997801, Israel
| | - J J LeRose
- Thomas Jefferson National Accelerator Facility, 12000 Jefferson Ave, Newport News, VA, 23606, USA
| | - R Lindgren
- University of Virginia, 382 McCormick Rd, Charlottesville, VA, 22904, USA
| | - E Long
- Kent State University, 800 E Summit St, Kent, OH, 44240, USA
| | - M Magne
- Clermont université, université Blaise Pascal, CNRS/IN2P3, 4 Avenue Blaise Pascal, 63178, Aubire Cedex, France
| | - J Mammei
- University of Massachusetts, 1126 Lederle Graduate Research Tower (LGRT), Amherst, MA, 01003, USA
| | - D J Margaziotis
- California State University, 5151 State University Dr, Los Angeles, CA, 90032, USA
| | - P Markowitz
- Florida International University, 11200 SW 8th St, Miami, FL, 33199, USA
| | - M Mazouz
- Faculté des Sciences de Monastir, Avenue de l'environnement, 5019, Monastir, Tunisia
| | - F Meddi
- INFN/Sezione Sanità, Viale Regina Elena 299, 00161, Roma, Italy
| | - D Meekins
- Thomas Jefferson National Accelerator Facility, 12000 Jefferson Ave, Newport News, VA, 23606, USA
| | - R Michaels
- Thomas Jefferson National Accelerator Facility, 12000 Jefferson Ave, Newport News, VA, 23606, USA
| | - M Mihovilovic
- University of Ljubljana, Kongresni trg 12, 1000, Ljubljana, Slovenia
| | - C Muñoz Camacho
- Institut de Physique Nucléaire CNRS-IN2P3, 15 rue Georges Clémenceau, 91406, Orsay, France
- Clermont université, université Blaise Pascal, CNRS/IN2P3, 4 Avenue Blaise Pascal, 63178, Aubire Cedex, France
| | - P Nadel-Turonski
- Thomas Jefferson National Accelerator Facility, 12000 Jefferson Ave, Newport News, VA, 23606, USA
| | - N Nuruzzaman
- Hampton University, 100 E Queen St, Hampton, VA, 23668, USA
| | - R Paremuzyan
- Institut de Physique Nucléaire CNRS-IN2P3, 15 rue Georges Clémenceau, 91406, Orsay, France
| | - A Puckett
- Los Alamos National Laboratory, Los Alamos, NM, 87545, USA
| | - V Punjabi
- Norfolk State University, 700 Park Avenue, Norfolk, VA, 23504, USA
| | - Y Qiang
- Thomas Jefferson National Accelerator Facility, 12000 Jefferson Ave, Newport News, VA, 23606, USA
| | - A Rakhman
- Syracuse University, 900 South Crouse Ave., Syracuse, NY, 13244, USA
| | - M N H Rashad
- Old Dominion University, Norfolk, 5115 Hampton Blvd, Norfolk, VA, 23529, USA
| | - S Riordan
- Stony Brook University, 100 Nicolls Rd, Stony Brook, NY, 11794, USA
| | - J Roche
- Ohio University, 123 University Terrace, 1 Ohio University, Athens, OH, 45701, USA
| | - G Russo
- INFN/Sezione di Catania, Via S. Sofia, 62, 95125, Catania, Italy
| | - F Sabatié
- Irfu, CEA, Université Paris-Saclay, 91191, Gif-sur-Yvette, France
| | - K Saenboonruang
- University of Virginia, 382 McCormick Rd, Charlottesville, VA, 22904, USA
- Kasetsart University, 50 Thanon Ngam Wong Wan, Khwaeng Lat Yao, Khet Chatuchak, Krung Thep, Maha Nakhon, 10900, Thailand
| | - A Saha
- Thomas Jefferson National Accelerator Facility, 12000 Jefferson Ave, Newport News, VA, 23606, USA
| | - B Sawatzky
- Thomas Jefferson National Accelerator Facility, 12000 Jefferson Ave, Newport News, VA, 23606, USA
- Temple University, 1801 N Broad St, Philadelphia, PA, 19122, USA
| | - L Selvy
- Kent State University, 800 E Summit St, Kent, OH, 44240, USA
| | - A Shahinyan
- Yerevan Physics Institute, 2. Alikhanian Br. Street, Yerevan, 0036, Armenia
| | - S Sirca
- University of Ljubljana, Kongresni trg 12, 1000, Ljubljana, Slovenia
| | - P Solvignon
- Thomas Jefferson National Accelerator Facility, 12000 Jefferson Ave, Newport News, VA, 23606, USA
- University of New Hampshire, 105 Main St, Durham, NH, 03824, USA
| | - M L Sperduto
- INFN/Sezione di Catania, Via S. Sofia, 62, 95125, Catania, Italy
| | - R Subedi
- George Washington University, 2121 I St NW, Washington, DC, 20052, USA
| | - V Sulkosky
- Massachusetts Institute of Technology, 77 Massachusetts Ave, Cambridge, MA, 02139, USA
| | - C Sutera
- INFN/Sezione di Catania, Via S. Sofia, 62, 95125, Catania, Italy
| | - W A Tobias
- University of Virginia, 382 McCormick Rd, Charlottesville, VA, 22904, USA
| | - G M Urciuoli
- INFN/Sezione di Roma, Piazzale Aldo Moro 2, 00185, Roma, Italy
| | - D Wang
- University of Virginia, 382 McCormick Rd, Charlottesville, VA, 22904, USA
| | - B Wojtsekhowski
- Thomas Jefferson National Accelerator Facility, 12000 Jefferson Ave, Newport News, VA, 23606, USA
| | - H Yao
- Temple University, 1801 N Broad St, Philadelphia, PA, 19122, USA
| | - Z Ye
- University of Virginia, 382 McCormick Rd, Charlottesville, VA, 22904, USA
| | - X Zhan
- Argonne National Laboratory, 9700 Cass Ave, Lemont, IL, 60439, USA
| | - J Zhang
- Thomas Jefferson National Accelerator Facility, 12000 Jefferson Ave, Newport News, VA, 23606, USA
| | - B Zhao
- College of William and Mary, Department of Physics, P.O. Box 8795, Williamsburg, VA, 23187, USA
| | - Z Zhao
- University of Virginia, 382 McCormick Rd, Charlottesville, VA, 22904, USA
| | - X Zheng
- University of Virginia, 382 McCormick Rd, Charlottesville, VA, 22904, USA
| | - P Zhu
- University of Virginia, 382 McCormick Rd, Charlottesville, VA, 22904, USA
| |
Collapse
|
90
|
Kong F, Liu Y, Zhang H, Yao H, Cerra-Franco A, Shiue K, Vile D, Wang W, Langer M, Watson G, Bartlett G, Diab K, Birdas T, Lautenschlaeger T, Jin J. MA 13.06 New Risk Factors for Overall Survival After SBRT in Early Stage NSCLC: A Role of RT Plan Optimization. J Thorac Oncol 2017. [DOI: 10.1016/j.jtho.2017.09.564] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
91
|
Camsonne A, Katramatou AT, Olson M, Acha A, Allada K, Anderson BD, Arrington J, Baldwin A, Chen JP, Choi S, Chudakov E, Cisbani E, Craver B, Decowski P, Dutta C, Folts E, Frullani S, Garibaldi F, Gilman R, Gomez J, Hahn B, Hansen JO, Higinbotham DW, Holmstrom T, Huang J, Iodice M, Jiang X, Kelleher A, Khrosinkova E, Kievsky A, Kuchina E, Kumbartzki G, Lee B, LeRose JJ, Lindgren RA, Lott G, Lu H, Marcucci LE, Margaziotis DJ, Markowitz P, Marrone S, Meekins D, Meziani ZE, Michaels R, Moffit B, Norum B, Petratos GG, Puckett A, Qian X, Rondon O, Saha A, Sawatzky B, Segal J, Shabestari M, Shahinyan A, Solvignon P, Sparveris N, Subedi RR, Suleiman R, Sulkosky V, Urciuoli GM, Viviani M, Wang Y, Wojtsekhowski BB, Yan X, Yao H, Zhang WM, Zheng X, Zhu L. JLab Measurements of the ^{3}He Form Factors at Large Momentum Transfers. Phys Rev Lett 2017; 119:162501. [PMID: 29099223 DOI: 10.1103/physrevlett.119.162501] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 10/31/2016] [Indexed: 06/07/2023]
Abstract
The charge and magnetic form factors, F_{C} and F_{M}, respectively, of ^{3}He are extracted in the kinematic range 25 fm^{-2}≤Q^{2}≤61 fm^{-2} from elastic electron scattering by detecting ^{3}He recoil nuclei and scattered electrons in coincidence with the two High Resolution Spectrometers of the Hall A Facility at Jefferson Lab. The measurements find evidence for the existence of a second diffraction minimum for the magnetic form factor at Q^{2}=49.3 fm^{-2} and for the charge form factor at Q^{2}=62.0 fm^{-2}. Both minima are predicted to exist in the Q^{2} range accessible by this Jefferson Lab experiment. The data are in qualitative agreement with theoretical calculations based on realistic interactions and accurate methods to solve the three-body nuclear problem.
Collapse
Affiliation(s)
- A Camsonne
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | | | - M Olson
- St. Norbert College, De Pere, Wisconsin 54115, USA
| | - A Acha
- Florida International University, Miami, Florida 33199, USA
| | - K Allada
- University of Kentucky, Lexington, Kentucky 40506, USA
| | | | - J Arrington
- Argonne National Laboratory, Argonne, Illinois 60439, USA
| | - A Baldwin
- Kent State University, Kent, Ohio 44242, USA
| | - J-P Chen
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - S Choi
- Seoul National University, Seoul 151-747, Korea
| | - E Chudakov
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - E Cisbani
- Istituto Nazionale di Fisica Nucleare, Sezione di Roma, 00185 Rome, Italy
- Istituto Superiore di Sanità, 00161 Rome, Italy
| | - B Craver
- University of Virginia, Charlottesville, Virginia 22904, USA
| | - P Decowski
- Smith College, Northampton, Massachusetts 01063, USA
| | - C Dutta
- University of Kentucky, Lexington, Kentucky 40506, USA
| | - E Folts
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - S Frullani
- Istituto Nazionale di Fisica Nucleare, Sezione di Roma, 00185 Rome, Italy
- Istituto Superiore di Sanità, 00161 Rome, Italy
| | - F Garibaldi
- Istituto Nazionale di Fisica Nucleare, Sezione di Roma, 00185 Rome, Italy
- Istituto Superiore di Sanità, 00161 Rome, Italy
| | - R Gilman
- Rutgers, The State University of New Jersey, Piscataway, New Jersey 08855, USA
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - J Gomez
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - B Hahn
- College of William and Mary, Williamsburg, Virginia 23185, USA
| | - J-O Hansen
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - D W Higinbotham
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - T Holmstrom
- Longwood University, Farmville, Virginia 23909, USA
| | - J Huang
- Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA
| | - M Iodice
- Istituto Nazionale di Fisica Nucleare, Sezione di Roma Tre, 00146 Rome, Italy
| | - X Jiang
- Rutgers, The State University of New Jersey, Piscataway, New Jersey 08855, USA
| | - A Kelleher
- College of William and Mary, Williamsburg, Virginia 23185, USA
| | | | - A Kievsky
- Istituto Nazionale di Fisica Nucleare, Sezione di Pisa, 56127 Pisa, Italy
| | - E Kuchina
- Rutgers, The State University of New Jersey, Piscataway, New Jersey 08855, USA
| | - G Kumbartzki
- Rutgers, The State University of New Jersey, Piscataway, New Jersey 08855, USA
| | - B Lee
- Seoul National University, Seoul 151-747, Korea
| | - J J LeRose
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - R A Lindgren
- University of Virginia, Charlottesville, Virginia 22904, USA
| | - G Lott
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - H Lu
- University of Science and Technology of China, Hefei, Anhui 230026, People's Republic of China
| | - L E Marcucci
- Istituto Nazionale di Fisica Nucleare, Sezione di Pisa, 56127 Pisa, Italy
- University of Pisa, 56127 Pisa, Italy
| | - D J Margaziotis
- California State University, Los Angeles, California 90032, USA
| | - P Markowitz
- Florida International University, Miami, Florida 33199, USA
| | - S Marrone
- Istituto Nazionale di Fisica Nucleare, Sezione di Bari and University of Bari, 70126 Bari, Italy
| | - D Meekins
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - Z-E Meziani
- Temple University, Philadelphia, Pennsylvania 19122, USA
| | - R Michaels
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - B Moffit
- Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA
| | - B Norum
- University of Virginia, Charlottesville, Virginia 22904, USA
| | | | - A Puckett
- Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA
| | - X Qian
- Duke University (TUNL), Durham, North Carolina 27708, USA
| | - O Rondon
- University of Virginia, Charlottesville, Virginia 22904, USA
| | - A Saha
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - B Sawatzky
- Temple University, Philadelphia, Pennsylvania 19122, USA
| | - J Segal
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - M Shabestari
- University of Virginia, Charlottesville, Virginia 22904, USA
| | - A Shahinyan
- Yerevan Physics Institute, Yerevan 375036, Armenia
| | - P Solvignon
- Argonne National Laboratory, Argonne, Illinois 60439, USA
| | - N Sparveris
- Kent State University, Kent, Ohio 44242, USA
- Temple University, Philadelphia, Pennsylvania 19122, USA
| | - R R Subedi
- University of Virginia, Charlottesville, Virginia 22904, USA
| | - R Suleiman
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - V Sulkosky
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - G M Urciuoli
- Istituto Nazionale di Fisica Nucleare, Sezione di Roma, 00185 Rome, Italy
| | - M Viviani
- Istituto Nazionale di Fisica Nucleare, Sezione di Pisa, 56127 Pisa, Italy
| | - Y Wang
- University of Illinois at Urbana Champagne, Urbana, Illinois 61801, USA
| | - B B Wojtsekhowski
- Thomas Jefferson National Accelerator Facility, Newport News, Virginia 23606, USA
| | - X Yan
- Seoul National University, Seoul 151-747, Korea
| | - H Yao
- Temple University, Philadelphia, Pennsylvania 19122, USA
| | - W-M Zhang
- Kent State University, Kent, Ohio 44242, USA
| | - X Zheng
- University of Virginia, Charlottesville, Virginia 22904, USA
| | - L Zhu
- University of Illinois at Urbana Champagne, Urbana, Illinois 61801, USA
| |
Collapse
|
92
|
Majewski T, Bondaruk J, Yao H, Lee S, Lee J, Zhang S, Choi W, Zhang L, Guo C, Dinney C, McConkey D, Baggerly K, Czerniak B. Molecular characterization of field effects and their progression to clinically evident bladder cancer. Urol Oncol 2017. [DOI: 10.1016/j.urolonc.2017.06.010] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
93
|
Long D, Kong F, Galle J, Tann M, Pi W, Furukawa Y, Haskins C, Yao H, Jin J, Cox J, Ellsworth S. Identification of Novel Prognostic Factors via Volumetric Analysis in Patients with Hepatocellular Carcinoma Treated With Liver Stereotactic Body Radiation Therapy. Int J Radiat Oncol Biol Phys 2017. [DOI: 10.1016/j.ijrobp.2017.06.1004] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
94
|
LIU Y, Yao H, Wang W, Shiue K, Cerra-Franco A, Vile D, Langer M, Watson G, Bartlett G, Sheski F, Jin J, Lautenschlaeger T, Kong F. Risk Factors for Radiation-Induced Lung Toxicity after Stereotactic Body Radiation Therapy in Patients with Non-Small Cell Lung Cancer. Int J Radiat Oncol Biol Phys 2017. [DOI: 10.1016/j.ijrobp.2017.06.1741] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
95
|
Kong F, LIU Y, Cerra-Franco A, Shiue K, Vile D, Yao H, Wang W, Langer M, Watson G, Bartlett G, Diab K, Birdas T, Timmerman R, Lautenschlaeger T, Jin J. Radiation to the Normal Lung May be an Important Risk Factor for Survival after Stereotactic Body Radiation Therapy in Non-Small Cell Lung Cancer. Int J Radiat Oncol Biol Phys 2017. [DOI: 10.1016/j.ijrobp.2017.06.1726] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
96
|
Zhao J, He L, Pan L, Liu Y, Yao H, Bao G. Effect of a lytic bacteriophage on rabbits experimentally infected with pathogenic Escherichia coli. World Rabbit Sci 2017. [DOI: 10.4995/wrs.2017.6395] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/21/2023]
Abstract
Pathogenic <em>Escherichia coli</em> (<em>E. coli</em>) is severely threatening the rabbit industry in China, and the concern over antibiotic-resistant bacteria has given rise to an urgent need for antibiotic alternatives. In this study, a member (ZRP1) of the <em>Myoviridae</em> family was isolated from rabbit faeces using a strain of rabbit atypical enteropathogenic <em>E. coli</em> (ZR1) as host. The one-step growth curve indicated that the latent period was around 25 to 30 min and the burst size was 144±31 plaque-forming unit/cell. The rate of phage-resistant mutation was 7×10<sup>–5</sup>±4×10<sup>–5</sup>. When the bacteriophage input at the multiplicity of infection (MOI) was 0.1, 1 or 10, the growth of host <em>E. coli</em> in broth was inhibited for 5 h. A single intravenous injection of ZRP1 at MOI 0.1, 1 or 10 significantly prolonged the survival time of rabbits which simultaneously received a lethal dose of ZR1.
Collapse
|
97
|
Yao H, He C, Deng L, Liao G. Enteral versus parenteral nutrition in critically ill patients with severe pancreatitis: a meta-analysis. Eur J Clin Nutr 2017; 72:66-68. [PMID: 28901335 DOI: 10.1038/ejcn.2017.139] [Citation(s) in RCA: 30] [Impact Index Per Article: 4.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/23/2016] [Revised: 06/19/2017] [Accepted: 07/27/2017] [Indexed: 01/13/2023]
Abstract
Whether enteral nutrition (EN) is superior to parenteral nutrition (PN) in critically ill patients with severe acute pancreatitis remains unknown. The objective of this meta-analysis was to assess the effects of EN versus PN on clinical outcomes in a subgroup of pancreatitis patients. Relevant randomized controlled trials (RCTs) were searched in Scopus, PubMed and Web of Science from inception to August 2016. Ultimately, five RCTs including 348 patients were enrolled in this analysis. Compared with PN, EN was associated with a significant reduction in overall mortality (risk ratio (RR)=0.36, 95% confidence interval (CI) 0.20-0.65, P=0.001) and the rate of multiple organ failure (RR=0.39, 95% CI 0.21-0.73, P=0.003). EN should be recommended as the preferred route of nutrition for critically ill patients with severe acute pancreatitis.
Collapse
Affiliation(s)
- H Yao
- Department of Intensive Care Unit of the Affiliated Nanhua Hospital, University of South China, Hengyang, China
| | - C He
- Department of Intensive Care Unit of the Affiliated Nanhua Hospital, University of South China, Hengyang, China
| | - L Deng
- Department of Intensive Care Unit of the Affiliated Nanhua Hospital, University of South China, Hengyang, China
| | - G Liao
- Department of Intensive Care Unit of the Affiliated Nanhua Hospital, University of South China, Hengyang, China
| |
Collapse
|
98
|
Qi BX, Yao H, Shang L, Sheng LP, Wang XC, Zhu L, Zhang XX, Wang JP, Fang DH. Evaluation of the role of 8-iso-PGF levels at multiple sites during intracranial hemorrhage in pediatric patients. Eur Rev Med Pharmacol Sci 2017; 21:4153-4160. [PMID: 29028082] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/07/2023]
Abstract
OBJECTIVE The present study was planned to explore the role of 8-isomeric-prostaglandinF2α (8-iso-PGF2α) levels at the multiple sites of cerebrospinal fluid in children with intracranial hemorrhage. PATIENTS AND METHODS 90 children with intracranial hemorrhage were admitted to Surgery Intensive Care Unit (SICU) of our hospital from January to December 2013 and were selected as study subjects. They were divided into group A (n=30), group B (n=30) and group C (n=30). The group A was given conventional treatment, the group B was treated with minimally invasive puncture and the group C was treated with cerebrospinal fluid decompression. After 1 d, 2 d, 3 d, and 7 d of hospitalization, enzyme-linked immunosorbent assay (ELISA) was used to detect the 8-iso-PGF2α levels in peripheral blood of children in all groups. On the day of admission and 10 d after treatment, 3 groups of children were implemented with brain nuclear magnetic resonance spectroscopy for metabolite analyses. RESULTS On the day of admission there were no significant differences in the 8-iso-PGF2α levels among group A, B and C. Further, after 1 d, 3 d, 7 d of hospital stay, the 8-iso-PGF2α levels in peripheral blood showed a gradual downward trend, and decline range of the group C was greater than that of group A and B (p < 0.05). After 10 days of treatment, there were significant differences in the bilateral temporal lobe and hippocampal NAA/Creatinine (Cr), Cho/Cr, mI/Cr and NAA/mI among group A, B, and C. The survival rate of group C was higher than that of group A and B (p < 0.05). On the other hand, the prevalence of sequelae was significantly lower than that of group A and B (p < 0.05). The amount of blood loss in children with intracranial hemorrhage was positively correlated with the levels of 8-iso-PGF2α in peripheral blood (r = 0.546, p < 0.05) as observed by Spearman correlation analysis. CONCLUSIONS 8-iso-PGF2α plays an important role in the pathogenesis of intracranial hemorrhage, and could be utilized as a biomarker of oxidative stress in children with intracranial hemorrhage. Further, cerebrospinal fluid decompression is a better method of treatment for intracranial hemorrhage.
Collapse
Affiliation(s)
- B-X Qi
- Departments of Intensive Care Unit, Xuzhou Children's Hospital, Xuzhou, Jiangsu Province, China.
| | | | | | | | | | | | | | | | | |
Collapse
|
99
|
Zhang Y, Hu Y, Wang JL, Yao H, Wang H, Liang L, Li C, Shi H, Chen Y, Fang JY, Xu J. Proteomic identification of ERP29 as a key chemoresistant factor activated by the aggregating p53 mutant Arg282Trp. Oncogene 2017; 36:5473-5483. [DOI: 10.1038/onc.2017.152] [Citation(s) in RCA: 18] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/29/2016] [Revised: 03/12/2017] [Accepted: 04/14/2017] [Indexed: 12/28/2022]
|
100
|
Wei F, Van Horn MH, Coombs MC, She X, Gonzales TS, Gonzalez YM, Scott JM, Iwasaki LR, Nickel JC, Yao H. A pilot study of nocturnal temporalis muscle activity in TMD diagnostic groups of women. J Oral Rehabil 2017; 44:517-525. [PMID: 28449265 DOI: 10.1111/joor.12517] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 04/22/2017] [Indexed: 01/28/2023]
Abstract
Temporomandibular disorder (TMD) incidences are believed to be related to parafunctional behaviours like teeth clenching. This pilot study aimed to (i) develop an automated clench-detection algorithm, and (ii) apply the algorithm to test for differences in nocturnal clenching in women with and without TMD. Subjects gave informed consent to participate. Adult women were categorised using Diagnostic Criteria for TMD according to presence/absence (+/-) of both TM joint disc placement (DD) and chronic pain (P) into two groups (+DD+P, -DD-P) with 12 subjects each. Surface temporalis electromyography was recorded during oral tasks performed by subjects at two laboratory sessions. The data were used to characterise muscle activity per N of bite force (μV/N) for each subject, develop the clench-detection algorithm and test its accuracy. Ambulatory surface temporalis electromyography was self-recorded by each subject over three nights and analysed using the algorithm and bite force (N) versus muscle activity μV/N calibrations. Bonferroni-adjusted homoscedastic t-tests assessed for significant between-group differences in clenching (P < 0·05). Sensitivity, specificity and accuracy of algorithm-detected laboratory clenches were all ≥96%. During self-recordings 95% of clenches had durations of <4 s and peak forces of <10 N in both groups. Mean clench durations were significantly longer (P = 0·042) in +DD+P (1·9 ± 0·8 s) than -DD-P subjects (1·4 ± 0·4 s). Mean temporalis duty factors (%clench time/total recording time) were significantly larger (P = 0·041) in +DD+P (0·47 ± 0·34%) than -DD-P (0·26 ±0·22%) subjects. Nocturnal temporalis muscle activities detected by a validated algorithm were longer per clench and recording time in +DD+P compared to -DD-P women.
Collapse
Affiliation(s)
- F Wei
- Department of Bioengineering, Clemson University, Clemson, SC, USA
| | - M H Van Horn
- Department of Bioengineering, Clemson University, Clemson, SC, USA
| | - M C Coombs
- Department of Bioengineering, Clemson University, Clemson, SC, USA.,Department of Oral Health Sciences, College of Dental Medicine, Medical University of South Carolina, Charleston, SC, USA
| | - X She
- Department of Bioengineering, Clemson University, Clemson, SC, USA
| | - T S Gonzales
- Department of Oral Health Sciences, College of Dental Medicine, Medical University of South Carolina, Charleston, SC, USA
| | - Y M Gonzalez
- Department of Oral Diagnostic Sciences, School of Dental Medicine, University at Buffalo, Buffalo, NY, USA
| | - J M Scott
- Department of Research and Graduate Programs, School of Dentistry, University of Missouri-Kansas City, Kansas City, MO, USA
| | - L R Iwasaki
- Department of Oral Diagnostic Sciences, School of Dental Medicine, University at Buffalo, Buffalo, NY, USA.,Departments of Orthodontics and Dentofacial Orthopedics, and Oral and Craniofacial Sciences, School of Dentistry, University of Missouri-Kansas City, Kansas City, MO, USA
| | - J C Nickel
- Department of Oral Diagnostic Sciences, School of Dental Medicine, University at Buffalo, Buffalo, NY, USA.,Departments of Orthodontics and Dentofacial Orthopedics, and Oral and Craniofacial Sciences, School of Dentistry, University of Missouri-Kansas City, Kansas City, MO, USA
| | - H Yao
- Department of Bioengineering, Clemson University, Clemson, SC, USA.,Department of Oral Health Sciences, College of Dental Medicine, Medical University of South Carolina, Charleston, SC, USA
| |
Collapse
|